<?xml version="1.0" encoding="iso-8859-1"?>
<!-- generator="FeedCreator 1.7.2" -->
<rss version="2.0">
    <channel>
        <title>Springer protocols feed by Immunology via MedWorm.com</title>
        <description>MedWorm.com provides a medical RSS filtering service. Over 6000 RSS medical sources are combined and output via different filters. This feed contains the latest items from the 'Springer protocols feed by Immunology' source.</description>
        <link><![CDATA[http://www.medworm.com/rss/search.php?qu=Springer+protocols+feed+by+Immunology&t=Springer+protocols+feed+by+Immunology&s=Search&f=source]]></link>
        <lastBuildDate>Sun, 27 Nov 2011 19:22:33 +0100</lastBuildDate>
        <item>
            <title>Overview of Membranes and Membrane Plates Used in Research and Diagnostic ELISPOT Assays</title>
            <link>http://www.medworm.com/index.php?rid=5284731&amp;cid=s_37124_3_f&amp;fid=37124&amp;url=http%3A%2F%2Fwww.springerprotocols.com%2FAbstract%2Fdoi%2F10.1007%2F978-1-61779-325-7_19</link>
            <description>Polyvinylidene fluoride (PVDF) membrane-bottomed, 96-well plates and 8-well strips constitute the formats in which the overwhelming majority of ELISPOT assays used in research and diagnostic applications are performed. PVDF is well suited for ELISPOT because it has a high antibody-binding capacity and because its white color provides an excellent backdrop for ELISPOT enumeration. Nitrocellulose (NC) and PVDF membranes and 96-well plates containing those membranes used in ELISPOT assays were initially commercialized for filtration applications and later optimized for a range of different protein analytical applications. An overview of the development and biotechnology applications of PVDF membrane is provided. Characteristics and attributes of the membrane that are relevant to ELISPOT are s...</description>
            <author>Springer protocols feed by Immunology</author>
            <type>news</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5284731</comments>
            <pubDate>Wed, 28 Sep 2011 04:00:00 +0100</pubDate>
            <guid isPermaLink="false">5284731</guid>        </item>
        <item>
            <title>IL-7 Addition Increases Spot Size and Number as Measured by T-SPOT.TB &amp;reg;</title>
            <link>http://www.medworm.com/index.php?rid=5284730&amp;cid=s_37124_3_f&amp;fid=37124&amp;url=http%3A%2F%2Fwww.springerprotocols.com%2FAbstract%2Fdoi%2F10.1007%2F978-1-61779-325-7_18</link>
            <description>The interferon-gamma (IFN-&amp;gamma;) release assay (IGRA) is an in vitro extension of the century-old in vivo tuberculin skin test, better known as the TST. Shortcomings to the TST are multifactorial and include limitations in sensitivity and specificity. IGRAs improve diagnostic specificity by using antigens not found in the Bacille Calmette-Gu&amp;eacute;rin, a vaccine given in most countries. IGRAs capture the IFN-&amp;gamma; produced by T cells in response to antigen stimulation. The ELISPOT immediately captures IFN-&amp;gamma; produced directly from each cell, resulting in the generation of a cellular &amp;ldquo;footprint.&amp;rdquo; The dimensions and intensity of the generated footprint indicate the avidity of the secreting cell. We show a further improvement in IGRAs by addition of interleukin-7 (IL-7)....</description>
            <author>Springer protocols feed by Immunology</author>
            <type>news</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5284730</comments>
            <pubDate>Wed, 28 Sep 2011 04:00:00 +0100</pubDate>
            <guid isPermaLink="false">5284730</guid>        </item>
        <item>
            <title>ELISPOT Assays to Enumerate Bovine IFN-&amp;gamma;-Secreting Cells for the Development of Novel Vaccines Against Bovine Tuberculosis</title>
            <link>http://www.medworm.com/index.php?rid=5284729&amp;cid=s_37124_3_f&amp;fid=37124&amp;url=http%3A%2F%2Fwww.springerprotocols.com%2FAbstract%2Fdoi%2F10.1007%2F978-1-61779-325-7_17</link>
            <description>Enumeration of antigen-specific cells after vaccination is one of the prime immunological parameters determined when developing vaccines. Due to their exquisite sensitivity (limits of detection can be below 1/100,000 cells), ELISPOT assays are therefore an important tool in vaccine development programs. This is particularly the case for vaccines against diseases that require protective cell-mediated immunity, such as tuberculosis. This chapter describes ELISPOT assays detecting bovine IFN-&amp;gamma;. (Source: Springer protocols feed by Immunology)</description>
            <author>Springer protocols feed by Immunology</author>
            <type>news</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5284729</comments>
            <pubDate>Wed, 28 Sep 2011 04:00:00 +0100</pubDate>
            <guid isPermaLink="false">5284729</guid>        </item>
        <item>
            <title>Detection of Vaccinia Virus-Specific IFN&amp;gamma; and IL-10 Secretion from Human PBMCs and CD8+ T Cells by ELISPOT</title>
            <link>http://www.medworm.com/index.php?rid=5284728&amp;cid=s_37124_3_f&amp;fid=37124&amp;url=http%3A%2F%2Fwww.springerprotocols.com%2FAbstract%2Fdoi%2F10.1007%2F978-1-61779-325-7_16</link>
            <description>High-throughput in vitro assays, which rapidly and succinctly assess the immune status of large cohorts of individuals, are essential tools for conducting population-based studies, including vaccine research. The enzyme-linked immunospot (ELISPOT) assay has emerged as a sensitive, reliable high-throughput tool to measure functional recall immunity by assessing the frequency of antigen-specific cytokine-secreting lymphocytes present in peripheral blood mononuclear cells (PBMCs). For the past 10 years, ELISPOT method has been the dominant platform and a standard for the cell-mediated immune (CMI) assays. ELISPOT assays are used extensively as a measure of CMI response to vaccines, including smallpox (vaccinia), following primary or secondary vaccination. Here, we present detailed methodology...</description>
            <author>Springer protocols feed by Immunology</author>
            <type>news</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5284728</comments>
            <pubDate>Wed, 28 Sep 2011 04:00:00 +0100</pubDate>
            <guid isPermaLink="false">5284728</guid>        </item>
        <item>
            <title>Response Determination Criteria for ELISPOT: Toward a Standard that Can Be Applied Across Laboratories</title>
            <link>http://www.medworm.com/index.php?rid=5284727&amp;cid=s_37124_3_f&amp;fid=37124&amp;url=http%3A%2F%2Fwww.springerprotocols.com%2FAbstract%2Fdoi%2F10.1007%2F978-1-61779-325-7_15</link>
            <description>ELISPOT assay readout is often dichomized as positive or negative responses according to prespecified criteria. However, these criteria can vary widely across institutions. The adoption of a common response criterion is a key step toward cross-laboratory comparability. This chapter describes the two main approaches to response determination, identifying the strengths and limitations of each. Nonparametric statistical tests and consideration of data quality are recommended and instructions provided for their ready implementation by nonstatisticians and statisticians alike. (Source: Springer protocols feed by Immunology)</description>
            <author>Springer protocols feed by Immunology</author>
            <type>news</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5284727</comments>
            <pubDate>Wed, 28 Sep 2011 04:00:00 +0100</pubDate>
            <guid isPermaLink="false">5284727</guid>        </item>
        <item>
            <title>Statistical Analysis of ELISPOT Assays</title>
            <link>http://www.medworm.com/index.php?rid=5284726&amp;cid=s_37124_3_f&amp;fid=37124&amp;url=http%3A%2F%2Fwww.springerprotocols.com%2FAbstract%2Fdoi%2F10.1007%2F978-1-61779-325-7_14</link>
            <description>Cytokine ELISPOT assays have emerged as a powerful tool for the detection of rare antigen-specific T cells in freshly isolated cell material, such as blood. While ELISPOT assays allow one to directly visualize and count extremely low frequencies of cytokine-secreting T cells among millions of nonsecreting bystander cells, the interpretation of ELISPOT data can become ambiguous when (a) spot numbers in antigen-containing wells are low, (b) spot counts in negative control wells are elevated, and particularly (c) when both of the above occur simultaneously. Thus, the primary task, even before statistics are employed, must be the optimization of the basic assay parameters and reagents such that the assay yields low background signal in the negative-control wells and the maximal number of antig...</description>
            <author>Springer protocols feed by Immunology</author>
            <type>news</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5284726</comments>
            <pubDate>Wed, 28 Sep 2011 04:00:00 +0100</pubDate>
            <guid isPermaLink="false">5284726</guid>        </item>
        <item>
            <title>Objective, User-Independent ELISPOT Data Analysis Based on Scientifically Validated Principles</title>
            <link>http://www.medworm.com/index.php?rid=5284725&amp;cid=s_37124_3_f&amp;fid=37124&amp;url=http%3A%2F%2Fwww.springerprotocols.com%2FAbstract%2Fdoi%2F10.1007%2F978-1-61779-325-7_13</link>
            <description>ELISPOT results used to be evaluated visually which, however, is inevitably subjective, inaccurate, and cumbersome. Even when applying automated image analysis to this end, the results are highly variable if the counting parameters are set subjectively. Since objective, accurate, and reproducible measurements are fundamental to science, major efforts have been undertaken over the last decade at CTL to understand the scientific principles behind ELISPOT data and to develop &amp;ldquo;intelligent&amp;rdquo; image analysis algorithms based on these principles. Thus, a spot recognition and gating algorithm was developed to automatically recognize the signatures of defined cell populations, such as T cells, discerning them from irrelevant cell types and noise. In this way, the science of ELISPOT data a...</description>
            <author>Springer protocols feed by Immunology</author>
            <type>news</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5284725</comments>
            <pubDate>Wed, 28 Sep 2011 04:00:00 +0100</pubDate>
            <guid isPermaLink="false">5284725</guid>        </item>
        <item>
            <title>Mathematical Algorithms for Automatic Search, Recognition, and Detection of Spots in ELISPOT Assay</title>
            <link>http://www.medworm.com/index.php?rid=5284724&amp;cid=s_37124_3_f&amp;fid=37124&amp;url=http%3A%2F%2Fwww.springerprotocols.com%2FAbstract%2Fdoi%2F10.1007%2F978-1-61779-325-7_12</link>
            <description>Accuracy of spot detection and quantification plays a critical role in the analysis of ELISPOT data. Differences in staining intensities of spots and their morphological variations make it difficult developing a reliable software application. We have developed an image recognition method allowing for the automatic detection of round objects (spots) on ELISPOT images independently of the registration conditions. The emphasis is done on objects of elliptical shape which is typical for a wide range of spots that can be analyzed by both monochrome and a dual-color version of our software. The method of subdivision of objects into groups is also described which is based on color attributes of spots. (Source: Springer protocols feed by Immunology)</description>
            <author>Springer protocols feed by Immunology</author>
            <type>news</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5284724</comments>
            <pubDate>Wed, 28 Sep 2011 04:00:00 +0100</pubDate>
            <guid isPermaLink="false">5284724</guid>        </item>
        <item>
            <title>How ELISPOT Morphology Reflects on the Productivity and Kinetics of Cells&amp;rsquo; Secretory Activity</title>
            <link>http://www.medworm.com/index.php?rid=5284723&amp;cid=s_37124_3_f&amp;fid=37124&amp;url=http%3A%2F%2Fwww.springerprotocols.com%2FAbstract%2Fdoi%2F10.1007%2F978-1-61779-325-7_11</link>
            <description>Over the past decade, ELISPOT has become well-established as a mainstream technology for the study of immune responses in vivo mainly due to its unique ability to detect rare antigen-specific lymphocytes ex vivo. The primary readout for ELISPOT assays has traditionally been the measurement of the frequency of analyte-secreting cells within a test population. While it has been generally appreciated that ELISPOT is a high-information-content assay system in which spot morphologies provide additional valuable information on the amount of analyte secreted by individual cells as well as the kinetics of the secretory process, the precise relationships involved have not been fully characterized and the specific relevant information &amp;shy;conveyed by spot morphologies has remained largely unexplore...</description>
            <author>Springer protocols feed by Immunology</author>
            <type>news</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5284723</comments>
            <pubDate>Wed, 28 Sep 2011 04:00:00 +0100</pubDate>
            <guid isPermaLink="false">5284723</guid>        </item>
        <item>
            <title>ELISPOT Assay as a Tool to Study the Effects of Stem Cells on Cytokine Secretion</title>
            <link>http://www.medworm.com/index.php?rid=5284722&amp;cid=s_37124_3_f&amp;fid=37124&amp;url=http%3A%2F%2Fwww.springerprotocols.com%2FAbstract%2Fdoi%2F10.1007%2F978-1-61779-325-7_9</link>
            <description>Mesenchymal stem cells (MSCs) have many regulatory effects (e.g., T-cell suppression) on various immune cells. As aberrant T-cell activation is a primary cause of many diseases, understanding the underlying mechanisms of how MSCs exert immunosuppression is an important issue with potential therapeutic implications. A group of cytokines was shown to be involved as soluble mediators in the immunosuppressive effects of MSCs. An enzyme-linked immunospot (ELISPOT) assay is an ideal method to find potential mediators involved in the MSC-immunosupporessive pathway; additionally, the ELISPOT assay can measure changes in the full spectrum of cytokines produced during T-cell activation in the presence of MSCs. Here, we show that during a mixed lymphocyte reaction, interleukin-10 (IL-10)-secreting sp...</description>
            <author>Springer protocols feed by Immunology</author>
            <type>news</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5284722</comments>
            <pubDate>Wed, 28 Sep 2011 04:00:00 +0100</pubDate>
            <guid isPermaLink="false">5284722</guid>        </item>
        <item>
            <title>ELISPOT Assay for Neuroscience Research: Studying TNF&amp;alpha; Secretion from Microglial Cells</title>
            <link>http://www.medworm.com/index.php?rid=5284721&amp;cid=s_37124_3_f&amp;fid=37124&amp;url=http%3A%2F%2Fwww.springerprotocols.com%2FAbstract%2Fdoi%2F10.1007%2F978-1-61779-325-7_8</link>
            <description>The major application of ELISPOT assays is to study secretion of cytokines and chemokines from immune system cells. We adapted this assay to study TNF&amp;alpha; secretion from microglial BV2 cells, which are similar in physiology to microglia in the nervous system. Stimulation of BV2 cells with 1 &amp;mu;g/mL LPS resulted in a robust secretion of TNF&amp;alpha;. Unlike uniform round spots formed by TNF&amp;alpha; secreted by immune system cells, BV2 cells produced spots with short zigzag &amp;ldquo;tails&amp;rdquo; indicating that BV2 cells were actively moving during the incubation. In spite of irregular shapes, spots could be easily counted using an ELISPOT reader. Our study has shown the feasibility of employing an ELISPOT assay as a tool for neuroscience research to study the mechanisms underlying protein se...</description>
            <author>Springer protocols feed by Immunology</author>
            <type>news</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5284721</comments>
            <pubDate>Wed, 28 Sep 2011 04:00:00 +0100</pubDate>
            <guid isPermaLink="false">5284721</guid>        </item>
        <item>
            <title>ELISPOT Assay as a Tool to Study Oxidative Stress in Lymphocytes</title>
            <link>http://www.medworm.com/index.php?rid=5284720&amp;cid=s_37124_3_f&amp;fid=37124&amp;url=http%3A%2F%2Fwww.springerprotocols.com%2FAbstract%2Fdoi%2F10.1007%2F978-1-61779-325-7_7</link>
            <description>Enzyme-linked immuno spot (ELISPOT) assay is widely used for vaccine development, cancer and AIDS research, and autoimmune disease studies. The output of ELISPOT assay is a formation of colored spots which appear at the sites of cells releasing cytokines, with each individual spot representing a single cytokine-releasing cell. We worked out a protocol to study oxidative stress in human peripheral blood lymphocytes by determining their potency to secrete IFN-gamma, IL-2, IL-4, IL-5, IL-8, and TNF-alpha in response to acute treatment with hydrogen peroxide. We show that hydrogen peroxide-induced oxidative stress can cause a &amp;sim;twofold decrease in the number of lymphocytes secreting the TH1 cytokines IFN-gamma and IL-2, as well as chemokines IL-8 and TNF-alpha. However, the number of cells ...</description>
            <author>Springer protocols feed by Immunology</author>
            <type>news</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5284720</comments>
            <pubDate>Wed, 28 Sep 2011 04:00:00 +0100</pubDate>
            <guid isPermaLink="false">5284720</guid>        </item>
        <item>
            <title>Dual- and Triple-Color Fluorospot</title>
            <link>http://www.medworm.com/index.php?rid=5284719&amp;cid=s_37124_3_f&amp;fid=37124&amp;url=http%3A%2F%2Fwww.springerprotocols.com%2FAbstract%2Fdoi%2F10.1007%2F978-1-61779-325-7_6</link>
            <description>Cytokine ELISPOT has become a powerful routine tool for the analysis of disease- as well as vaccine-induced T-cell responses. The method is limited, however, in that only one cytokine at a time is assessed. Fluorospot is based on the principle of ELISPOT, but facilitates the analysis of single cells secreting several cytokines, e.g., polyfunctional T cells, suggested to be of protective importance in various infectious diseases. By detecting each cytokine with a specific fluorophore and analyzing differentially colored spots by fluorophore-&amp;shy;specific filter systems, cells producing single or multiple cytokines are identified. Fluorospot maintains the simplicity and sensitivity of the ELISPOT while taking the analysis a step forward toward multiplex analysis. (Source: Springer protocols ...</description>
            <author>Springer protocols feed by Immunology</author>
            <type>news</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5284719</comments>
            <pubDate>Wed, 28 Sep 2011 04:00:00 +0100</pubDate>
            <guid isPermaLink="false">5284719</guid>        </item>
        <item>
            <title>Combining ELISPOT and ELISA to Measure Amounts of Cytokines Secreted by a Single Cell</title>
            <link>http://www.medworm.com/index.php?rid=5284718&amp;cid=s_37124_3_f&amp;fid=37124&amp;url=http%3A%2F%2Fwww.springerprotocols.com%2FAbstract%2Fdoi%2F10.1007%2F978-1-61779-325-7_10</link>
            <description>Enzyme-linked immunospot (ELISPOT) assay allows for the determination of the frequency of &amp;shy;cytokine-secreting cells, but does not answer the question of how much cytokine is secreted per cell. In our study, we combined ELISPOT and ELISA assays and developed a protocol to calculate the amount of IFN gamma secreted by each cell. A suspension of human peripheral blood mononuclear cells was split into two pools and cells from one pool were cultured in a regular ELISPOT plate, whereas cells from the other pool were cultured in an uncoated, &amp;ldquo;blank,&amp;rdquo; ELISPOT plate. After finishing the incubations, the amount of IFN gamma was measured by ELISA in culture media collected from both plates. The &amp;ldquo;blank&amp;rdquo; plate served to measure a total amount of secreted IFN gamma, whereas t...</description>
            <author>Springer protocols feed by Immunology</author>
            <type>news</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5284718</comments>
            <pubDate>Wed, 28 Sep 2011 04:00:00 +0100</pubDate>
            <guid isPermaLink="false">5284718</guid>        </item>
        <item>
            <title>Analyzing Cellular Immunity to AAV in a Canine Model Using ELISPOT Assay</title>
            <link>http://www.medworm.com/index.php?rid=5284717&amp;cid=s_37124_3_f&amp;fid=37124&amp;url=http%3A%2F%2Fwww.springerprotocols.com%2FAbstract%2Fdoi%2F10.1007%2F978-1-61779-325-7_5</link>
            <description>Adeno-associated viral (AAV) vector-mediated gene transfer represents a promising gene replacement strategy for treating various genetic diseases. One obstacle in using viral-derived vectors for in vivo gene delivery is the development of host immune responses to the vector. Recent studies have demonstrated cellular immune responses specific to capsid proteins of various AAV serotypes in animal models and in human trials for different diseases. We developed a canine-specific ELISPOT assay to detect such immunity in dogs received AAV treatment. Here, we describe in detail the use of a constructed panel of overlapping peptides spanning the entire VP1 sequence of AAV capsid protein to detect specific T-cell responses in peripheral blood in dogs following intramuscular injection of AAV. This h...</description>
            <author>Springer protocols feed by Immunology</author>
            <type>news</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5284717</comments>
            <pubDate>Wed, 28 Sep 2011 04:00:00 +0100</pubDate>
            <guid isPermaLink="false">5284717</guid>        </item>
        <item>
            <title>Utilization of Feline ELISPOT for Mapping Vaccine Epitopes</title>
            <link>http://www.medworm.com/index.php?rid=5284716&amp;cid=s_37124_3_f&amp;fid=37124&amp;url=http%3A%2F%2Fwww.springerprotocols.com%2FAbstract%2Fdoi%2F10.1007%2F978-1-61779-325-7_4</link>
            <description>A commercial feline immunodeficiency virus (FIV) vaccine consisting of inactivated dual-subtype viruses was released in the USA in 2002 and released subsequently over the next 6 years in Canada, Australia, New Zealand, and Japan. Based on the genetic, morphologic, and biochemical similarities between FIV and human immunodeficiency virus-1 (HIV-1), FIV infection of domestic cats is being used as a small animal model of HIV/AIDS vaccine. Studies on prototype and commercial FIV vaccines provide new insights to the types of immunity and the vaccine epitopes required for an effective human HIV-1 vaccine. ELISPOT assays to detect cytokines, chemokines, and cytolytic mediators are widely used to measure the magnitude and the types of cellular immunity produced by vaccination. Moreover, such appro...</description>
            <author>Springer protocols feed by Immunology</author>
            <type>news</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5284716</comments>
            <pubDate>Wed, 28 Sep 2011 04:00:00 +0100</pubDate>
            <guid isPermaLink="false">5284716</guid>        </item>
        <item>
            <title>Equine ELISPOT Assay to Study Secretion of IFN&amp;gamma; and IL-4 from Peripheral Blood Mononuclear Cells</title>
            <link>http://www.medworm.com/index.php?rid=5284715&amp;cid=s_37124_3_f&amp;fid=37124&amp;url=http%3A%2F%2Fwww.springerprotocols.com%2FAbstract%2Fdoi%2F10.1007%2F978-1-61779-325-7_3</link>
            <description>Human and mouse immune system cells are the most frequently used specimens in ELISPOT assays. In an effect to expand the application of ELISPOT assay to other species, we developed matched antibody pairs for ready-to-use kits designed for studying the frequency of equine IFN&amp;gamma;- and IL-4-secreting peripheral blood mononuclear cells (PBMCs). Equine PBMCs were stimulated with either concanavalin A (Con A) or calcium ionomycin mixed with phorbol 12-myristate 13-acetate (CaI + PMA). We found that Con A, in general, had a more profound stimulating effect than CaI + PMA on IL-4 secretion, whereas both stimulatory and inhibitory effects were observed on IFN&amp;gamma; secretion. Our data demonstrate a large dynamic range in IFN&amp;gamma; and IL-4 secretion among different donors, which may reflect a...</description>
            <author>Springer protocols feed by Immunology</author>
            <type>news</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5284715</comments>
            <pubDate>Wed, 28 Sep 2011 04:00:00 +0100</pubDate>
            <guid isPermaLink="false">5284715</guid>        </item>
        <item>
            <title>The Impact of Harmonization on ELISPOT Assay Performance</title>
            <link>http://www.medworm.com/index.php?rid=5284714&amp;cid=s_37124_3_f&amp;fid=37124&amp;url=http%3A%2F%2Fwww.springerprotocols.com%2FAbstract%2Fdoi%2F10.1007%2F978-1-61779-325-7_2</link>
            <description>During more than 25 years of application in immunological sciences, ELISPOT has been established as a routine, robust, versatile, and reliable assay. From basic research to clinical immune monitoring, ELISPOT is being used to address the quantification and (to a lesser extent) functional characterization of immune cells secreting different molecules in the context of health and disease, immune intervention, and therapy in humans and other species [Kalyuzhny (Ed.) (2005) Handbook of Elispot: methods and protocols, Vol. 302, Humana Press Inc., Totowa, NJ]. Over the last decade, ELISPOT assays have been increasingly implemented as an immune-monitoring tool in clinical trials [Schmittel et al. J Immunother 23:289&amp;ndash;295, 2000; Whiteside Immunol Invest 29:149&amp;ndash;162, 2000; Nagata et al. A...</description>
            <author>Springer protocols feed by Immunology</author>
            <type>news</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5284714</comments>
            <pubDate>Wed, 28 Sep 2011 04:00:00 +0100</pubDate>
            <guid isPermaLink="false">5284714</guid>        </item>
        <item>
            <title>Unique Strengths of ELISPOT for T Cell Diagnostics</title>
            <link>http://www.medworm.com/index.php?rid=5284713&amp;cid=s_37124_3_f&amp;fid=37124&amp;url=http%3A%2F%2Fwww.springerprotocols.com%2FAbstract%2Fdoi%2F10.1007%2F978-1-61779-325-7_1</link>
            <description>The T cell system plays an essential role in infections, allergic reactions, tumor and transplant rejection, as well as autoimmune diseases. It does so by the selective engagement of different antigen-specific effector cell lineages that differentially secrete cytokines and other effector molecules. These T cell subsets may or may not have cytolytic activity, can preferentially migrate to different tissues, and display variable capabilities to expand clonally. The quest of T cell immune diagnostics is to understand which specific effector function and T cell lineage is associated with a given clinical outcome, be it positive or adverse. No single assay can measure all of the relevant parameters. In this chapter, we review the unique contributions that ELISPOT assays can make toward underst...</description>
            <author>Springer protocols feed by Immunology</author>
            <type>news</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5284713</comments>
            <pubDate>Wed, 28 Sep 2011 04:00:00 +0100</pubDate>
            <guid isPermaLink="false">5284713</guid>        </item>
        <item>
            <title>Ratiometric Analysis of Subcellular Recruitment of Fc Receptors During Phagocytosis</title>
            <link>http://www.medworm.com/index.php?rid=4969595&amp;cid=s_37124_3_f&amp;fid=37124&amp;url=http%3A%2F%2Fwww.springerprotocols.com%2FAbstract%2Fdoi%2F10.1007%2F978-1-61779-139-0_9</link>
            <description>Numerous immune receptors have the ability to mediate phagocytosis of large particles by triggering dynamic local rearrangement of the cytoskeleton and cell membrane. Different receptors can be differentially recruited to sites of particle binding, which in turn can have important functional consequences with respect to engulfment and downstream signaling. Using Fc&amp;gamma; receptor-mediated phagocytosis of IgG-coated particles as a model, we describe a method for analyzing nascent phagocytic cups and quantifying relative receptor levels at sites of phagocytosis. This technique is based on a ratiometric analysis of subcellular localization of exogenously expressed receptors carrying different fluorescent protein tags. This approach could be applied more generally to the analysis of surface m...</description>
            <author>Springer protocols feed by Immunology</author>
            <type>news</type>
        <comments>http://www.medworm.com/rss/comments.php?id=4969595</comments>
            <pubDate>Tue, 21 Jun 2011 23:00:00 +0100</pubDate>
            <guid isPermaLink="false">4969595</guid>        </item>
        <item>
            <title>Determining Fc&amp;epsilon;RI Diffusional Dynamics via Single Quantum Dot Tracking</title>
            <link>http://www.medworm.com/index.php?rid=4969594&amp;cid=s_37124_3_f&amp;fid=37124&amp;url=http%3A%2F%2Fwww.springerprotocols.com%2FAbstract%2Fdoi%2F10.1007%2F978-1-61779-139-0_8</link>
            <description>Single-particle tracking (SPT) using fluorescent quantum dots (QDs) provides high-resolution spatial&amp;ndash;temporal information on receptor dynamics that cannot be obtained through traditional biochemical techniques. In particular, the high brightness and photostability of QDs make them ideal probes for SPT on living cells. We have shown that QD-labeled IgE can be used to characterize the dynamics of the high-affinity IgE Receptor. Here, we describe protocols for (1) coupling QDs to IgE, (2) tracking individual QD-bound receptors, and (3) analyzing one- and two-color tracking data. (Source: Springer protocols feed by Immunology)</description>
            <author>Springer protocols feed by Immunology</author>
            <type>news</type>
        <comments>http://www.medworm.com/rss/comments.php?id=4969594</comments>
            <pubDate>Tue, 21 Jun 2011 23:00:00 +0100</pubDate>
            <guid isPermaLink="false">4969594</guid>        </item>
        <item>
            <title>Cell-Based Reporter Assay to Analyze Activation of Nod1 and Nod2</title>
            <link>http://www.medworm.com/index.php?rid=4969593&amp;cid=s_37124_3_f&amp;fid=37124&amp;url=http%3A%2F%2Fwww.springerprotocols.com%2FAbstract%2Fdoi%2F10.1007%2F978-1-61779-139-0_7</link>
            <description>Nod1 and Nod2 are pattern recognition receptors of the mammalian innate immune system. They respond to bacterial peptidoglycan fragments and are implicated in host defense against a variety of &amp;shy;different bacterial pathogens. Recent studies furthermore support additional functions of these proteins in the control of adaptive immune responses and intestinal homeostasis. Activation of Nod1 and Nod2 by their cognate elicitors triggers inflammatory responses driven by the activation of NF-&amp;kappa;B and MAPK pathways. In this chapter, we describe a quick and reliable cell-based assay using a luciferase reporter to measure Nod1- and Nod2-mediated NF-&amp;kappa;B activation. The described protocol was successfully applied to analyze the influences of overexpressed proteins and siRNA-mediated knock-...</description>
            <author>Springer protocols feed by Immunology</author>
            <type>news</type>
        <comments>http://www.medworm.com/rss/comments.php?id=4969593</comments>
            <pubDate>Tue, 21 Jun 2011 23:00:00 +0100</pubDate>
            <guid isPermaLink="false">4969593</guid>        </item>
        <item>
            <title>Analysis of Receptor&amp;ndash;Ligand Interactions by Surface Plasmon Resonance</title>
            <link>http://www.medworm.com/index.php?rid=4969592&amp;cid=s_37124_3_f&amp;fid=37124&amp;url=http%3A%2F%2Fwww.springerprotocols.com%2FAbstract%2Fdoi%2F10.1007%2F978-1-61779-139-0_6</link>
            <description>Many immunological responses are often regulated by cell surface receptors in cell&amp;ndash;cell recognition events. Such immune receptors on the cell surface typically exhibit low-affinity and fast-kinetic ligand interactions (e.g., K
       d in the &amp;mu;M range, k
       off &amp;thinsp;= &amp;thinsp;10&amp;minus;2 to 20 s&amp;minus;1). Real-time surface plasmon resonance (SPR) detection systems are generally useful for determining these binding parameters. However, several technical points should be considered because the determination of low-affinity binding and fast kinetics is often rather difficult. Here, we introduce a general procedure for SPR experiments and, moreover, show typical examples for ligand binding of immune cell surface receptors, including experimentally useful tips. We also show how t...</description>
            <author>Springer protocols feed by Immunology</author>
            <type>news</type>
        <comments>http://www.medworm.com/rss/comments.php?id=4969592</comments>
            <pubDate>Tue, 21 Jun 2011 23:00:00 +0100</pubDate>
            <guid isPermaLink="false">4969592</guid>        </item>
        <item>
            <title>Innate Immune Receptors for Nucleic Acids</title>
            <link>http://www.medworm.com/index.php?rid=4969591&amp;cid=s_37124_3_f&amp;fid=37124&amp;url=http%3A%2F%2Fwww.springerprotocols.com%2FAbstract%2Fdoi%2F10.1007%2F978-1-61779-139-0_5</link>
            <description>The innate immune system has evolved to detect microbes and sterile tissue damage with the help of a series of signaling receptors. One key strategy is to detect infectious microbes or host cell damage by recognizing nucleic acids that are modified or appear in compartment normally devoid of nucleic acids. Here, we describe two methods that allow studying the molecular interaction between various nucleic acid recognizing signaling receptors with their ligands. A ligand pull-down assay can be used to show a known interaction between a ligand and its receptor or the method can be utilized as a discovery approach to identify an unknown receptor to a given ligand. An AlphaScreen experiment can be set up to assess the ligand binding affinity to a given receptor. (Source: Springer protocols feed...</description>
            <author>Springer protocols feed by Immunology</author>
            <type>news</type>
        <comments>http://www.medworm.com/rss/comments.php?id=4969591</comments>
            <pubDate>Tue, 21 Jun 2011 23:00:00 +0100</pubDate>
            <guid isPermaLink="false">4969591</guid>        </item>
        <item>
            <title>Construction, Expression, and Purification of Chimeric Protein Reagents Based on Immunoglobulin Fc Regions</title>
            <link>http://www.medworm.com/index.php?rid=4969590&amp;cid=s_37124_3_f&amp;fid=37124&amp;url=http%3A%2F%2Fwww.springerprotocols.com%2FAbstract%2Fdoi%2F10.1007%2F978-1-61779-139-0_4</link>
            <description>We describe a set of methods for subcloning, expression, and purification of chimeric protein reagents containing a protein domain (or domains) of interest fused to a C-terminal moiety derived from the Fc region of either IgG or IgM. (Source: Springer protocols feed by Immunology)</description>
            <author>Springer protocols feed by Immunology</author>
            <type>news</type>
        <comments>http://www.medworm.com/rss/comments.php?id=4969590</comments>
            <pubDate>Tue, 21 Jun 2011 23:00:00 +0100</pubDate>
            <guid isPermaLink="false">4969590</guid>        </item>
        <item>
            <title>Assessment of the Recycling of the Membrane-Bound Chemokine, CX3CL1</title>
            <link>http://www.medworm.com/index.php?rid=4969589&amp;cid=s_37124_3_f&amp;fid=37124&amp;url=http%3A%2F%2Fwww.springerprotocols.com%2FAbstract%2Fdoi%2F10.1007%2F978-1-61779-139-0_10</link>
            <description>Fractalkine (CX3CL1) is a membrane-anchored chemokine whose N-terminus contains a unique CX3C motif that is cleaved and released. The membrane-bound form functions as an adhesion molecule and the secreted form as a chemotactic factor. Like other chemokines, CX3CL1 is regulated at the levels of transcription and translation. Recent evidence points to additional functional regulation by cellular trafficking owing to the unique transmembrane structure. CX3CL1 is the only chemokine known to undergo constitutive internalization. To understand mechanisms governing the regulation and processing of such membrane-bound proteins, it is vital to study their subcellular distribution and transport. The methods outlined in this chapter describe (1) transfection of mammalian cells with plasmids encoding ...</description>
            <author>Springer protocols feed by Immunology</author>
            <type>news</type>
        <comments>http://www.medworm.com/rss/comments.php?id=4969589</comments>
            <pubDate>Tue, 21 Jun 2011 23:00:00 +0100</pubDate>
            <guid isPermaLink="false">4969589</guid>        </item>
        <item>
            <title>Probing the Plasma Membrane Structure of Immune Cells Through the Analysis of Membrane Sheets by Electron Microscopy</title>
            <link>http://www.medworm.com/index.php?rid=4969588&amp;cid=s_37124_3_f&amp;fid=37124&amp;url=http%3A%2F%2Fwww.springerprotocols.com%2FAbstract%2Fdoi%2F10.1007%2F978-1-61779-139-0_12</link>
            <description>This chapter describes a method to generate plasma membrane sheets that are large enough to visualize the membrane architecture and perform quantitative analyses of protein distributions. This procedure places the sheets on electron microscopy grids, parallel to the imaging plane of the microscope, where they can be characterized by transmission electron microscopy. The basic principle of the technique is that cells are broken open (&amp;ldquo;ripped&amp;rdquo;) through mechanical forces applied by the separation of two opposing surfaces sandwiching the cell, with one of the surfaces coated onto an EM grid. The exposed inner membrane surfaces can then be visualized with electron dense stains and specific proteins can be detected with gold conjugated probes. (Source: Springer protocols feed by Immu...</description>
            <author>Springer protocols feed by Immunology</author>
            <type>news</type>
        <comments>http://www.medworm.com/rss/comments.php?id=4969588</comments>
            <pubDate>Tue, 21 Jun 2011 23:00:00 +0100</pubDate>
            <guid isPermaLink="false">4969588</guid>        </item>
        <item>
            <title>Measuring Immune Receptor Mobility by Fluorescence Recovery After Photobleaching</title>
            <link>http://www.medworm.com/index.php?rid=4969587&amp;cid=s_37124_3_f&amp;fid=37124&amp;url=http%3A%2F%2Fwww.springerprotocols.com%2FAbstract%2Fdoi%2F10.1007%2F978-1-61779-139-0_11</link>
            <description>We describe here general approaches for FRAP using green fluorescent protein fusion proteins. (Source: Springer protocols feed by Immunology)</description>
            <author>Springer protocols feed by Immunology</author>
            <type>news</type>
        <comments>http://www.medworm.com/rss/comments.php?id=4969587</comments>
            <pubDate>Tue, 21 Jun 2011 23:00:00 +0100</pubDate>
            <guid isPermaLink="false">4969587</guid>        </item>
        <item>
            <title>Rapamycin-Based Inducible Translocation Systems for Studying Phagocytosis</title>
            <link>http://www.medworm.com/index.php?rid=4969586&amp;cid=s_37124_3_f&amp;fid=37124&amp;url=http%3A%2F%2Fwww.springerprotocols.com%2FAbstract%2Fdoi%2F10.1007%2F978-1-61779-139-0_13</link>
            <description>Phagocytosis is an immune receptor-mediated process whereby cells engulf large particles. The process is dynamic and requires several localized factors acting in concert with and sequentially after the engagement of immune receptors to envelope the particle. Once the particle is internalized, the nascent &amp;shy;phagosome undergoes a series of events leading to its maturation to the microbicidal phagolysosome. Investigating these dynamic and temporally controlled series of events in live cells requires noninvasive methods. The ability to rapidly recruit the proteins of interest to the sites of phagocytosis or to nascent phagosomes would help dissect the regulatory mechanisms involved during phagocytosis. Here, we describe a general approach to express in RAW264.7 murine macrophages, a genetic...</description>
            <author>Springer protocols feed by Immunology</author>
            <type>news</type>
        <comments>http://www.medworm.com/rss/comments.php?id=4969586</comments>
            <pubDate>Tue, 21 Jun 2011 23:00:00 +0100</pubDate>
            <guid isPermaLink="false">4969586</guid>        </item>
        <item>
            <title>Micropatterned Ligand Arrays to Study Spatial Regulation in Fc Receptor Signaling</title>
            <link>http://www.medworm.com/index.php?rid=4969585&amp;cid=s_37124_3_f&amp;fid=37124&amp;url=http%3A%2F%2Fwww.springerprotocols.com%2FAbstract%2Fdoi%2F10.1007%2F978-1-61779-139-0_14</link>
            <description>Fc receptor signaling plays a fundamental role in immune responses. A plethora of Fc &amp;shy;receptors (e.g., Fc gamma, Fc-alpha, and Fc-epsilon) are expressed on different immune cells, including natural killer cells, macrophages, mast cells, and neutrophils. Receptor clustering and activation by multivalent ligands or opsonized particles induce a signaling cascade that leads to targeted secretion of chemical mediators (i.e., histamine, cytokines, and chemokines) and phagocytosis, among other responses. Spatial targeting and compartmentalization are common mechanisms of regulation in Fc receptor signaling. However, the tools for studying these dynamic interactions have been limited. To overcome these limitations in our model system, microfabricated surfaces containing spatially defined ligan...</description>
            <author>Springer protocols feed by Immunology</author>
            <type>news</type>
        <comments>http://www.medworm.com/rss/comments.php?id=4969585</comments>
            <pubDate>Tue, 21 Jun 2011 23:00:00 +0100</pubDate>
            <guid isPermaLink="false">4969585</guid>        </item>
        <item>
            <title>CELLISA: Reporter Cell-Based Immunization and Screening of Hybridomas Specific for Cell Surface Antigens</title>
            <link>http://www.medworm.com/index.php?rid=4969584&amp;cid=s_37124_3_f&amp;fid=37124&amp;url=http%3A%2F%2Fwww.springerprotocols.com%2FAbstract%2Fdoi%2F10.1007%2F978-1-61779-139-0_15</link>
            <description>Monoclonal antibodies (mAbs) specific for cell surface antigens are an invaluable tool to study immune receptor expression and function. Here, we outline a generalized reporter cell-based approach to the generation and high-throughput screening of mAbs specific for cell surface antigens. Termed CELLISA, this technology hinges upon the capture of hybridoma supernatants in mAb arrays that facilitate ligation of an antigen of interest displayed on BWZ reporter cells in the form of a CD3&amp;zeta;-fusion chimeric antigen receptor (zCAR); in turn, specific mAb-mediated cross-linking of zCAR on BWZ cells results in the production of &amp;beta;-galactosidase enzyme (&amp;beta;-gal), which can be assayed colorimetrically. Importantly, the BWZ reporter cells bearing the zCAR of interest may be used for immuniz...</description>
            <author>Springer protocols feed by Immunology</author>
            <type>news</type>
        <comments>http://www.medworm.com/rss/comments.php?id=4969584</comments>
            <pubDate>Tue, 21 Jun 2011 23:00:00 +0100</pubDate>
            <guid isPermaLink="false">4969584</guid>        </item>
        <item>
            <title>Transfection-Based Genomic Readout for Identifying Rare Transcriptional Splice Variants</title>
            <link>http://www.medworm.com/index.php?rid=4969583&amp;cid=s_37124_3_f&amp;fid=37124&amp;url=http%3A%2F%2Fwww.springerprotocols.com%2FAbstract%2Fdoi%2F10.1007%2F978-1-61779-139-0_17</link>
            <description>Understanding the transcriptome, defined as the complete transcriptional component of the genome, is far more complex than originally considered. Even with the near fully resolved human and mouse genomes, for which extensive databases of transcribed sequence data (e.g., expressed sequence tags) are available, it is presently not possible to experimentally recover or computationally predict the full range of transcription products that derive from multiexon genes. Many genes are tightly regulated, which could include alternative processing of RNA, and lead to significant underrepresentation of many transcripts. A multitude of factors in addition to cell lineage- and developmental stage-specific expression as well as shortcomings in computational methods result in a less than complete unders...</description>
            <author>Springer protocols feed by Immunology</author>
            <type>news</type>
        <comments>http://www.medworm.com/rss/comments.php?id=4969583</comments>
            <pubDate>Tue, 21 Jun 2011 23:00:00 +0100</pubDate>
            <guid isPermaLink="false">4969583</guid>        </item>
        <item>
            <title>Use of Colloidal Silica-Beads for the Isolation of Cell-Surface Proteins for Mass Spectrometry-Based Proteomics</title>
            <link>http://www.medworm.com/index.php?rid=4969582&amp;cid=s_37124_3_f&amp;fid=37124&amp;url=http%3A%2F%2Fwww.springerprotocols.com%2FAbstract%2Fdoi%2F10.1007%2F978-1-61779-139-0_16</link>
            <description>Chaney and Jacobson first introduced the colloidal silica-bead protocol for the coating of cellular plasma membranes in the early 1980s. Since then, this method has been successfully incorporated into a wide range of in vitro and in vivo applications for the isolation of cell-surface proteins. The principle is simple &amp;ndash; cationic colloidal silica microbeads are introduced to a suspension or monolayer of cells in culture. Electrostatic interactions between the beads and the negatively charged plasma membrane, followed by cross-linking to the membrane with an anionic polymer, ensure attachment and maintain the native protein conformation. Cells are subsequently ruptured, and segregation of the resulting plasma membrane sheets from the remaining&amp;shy; cell constituents is achieved by ultra...</description>
            <author>Springer protocols feed by Immunology</author>
            <type>news</type>
        <comments>http://www.medworm.com/rss/comments.php?id=4969582</comments>
            <pubDate>Tue, 21 Jun 2011 23:00:00 +0100</pubDate>
            <guid isPermaLink="false">4969582</guid>        </item>
        <item>
            <title>Characterizing Somatic Hypermutation and Gene Conversion in the Chicken DT40 Cell System</title>
            <link>http://www.medworm.com/index.php?rid=4969581&amp;cid=s_37124_3_f&amp;fid=37124&amp;url=http%3A%2F%2Fwww.springerprotocols.com%2FAbstract%2Fdoi%2F10.1007%2F978-1-61779-139-0_18</link>
            <description>The secondary immunoglobulin gene diversification processes, somatic hypermutation (SHM), immunoglobulin gene conversion (GCV), and class switch recombination, are important for efficient humoral immune responses. They require the action of activation-induced cytidine deaminase, an enzyme that deaminates cytosine in the context of single-stranded DNA. The chicken DT40 B-cell line is an important model system for exploring the mechanisms of SHM and GCV, as both processes occur constitutively without the need for stimulation. In addition, standard gene targeting strategies can be used for defined manipulations of the DT40 genome. Thus, these cells represent an excellent model of choice for genetic studies of SHM and GCV. Problems arising from defects in early B-cell development that are of c...</description>
            <author>Springer protocols feed by Immunology</author>
            <type>news</type>
        <comments>http://www.medworm.com/rss/comments.php?id=4969581</comments>
            <pubDate>Tue, 21 Jun 2011 23:00:00 +0100</pubDate>
            <guid isPermaLink="false">4969581</guid>        </item>
        <item>
            <title>Characterizing Immune Receptors from New Genome Sequences</title>
            <link>http://www.medworm.com/index.php?rid=4969580&amp;cid=s_37124_3_f&amp;fid=37124&amp;url=http%3A%2F%2Fwww.springerprotocols.com%2FAbstract%2Fdoi%2F10.1007%2F978-1-61779-139-0_19</link>
            <description>We describe here a computational strategy to characterize homologs of immune receptors and also to identify putative novel receptors from newly assembled genome sequences. The description of these protocols is aimed at a typical immunologist, and a substantial knowledge of bioinformatics is not expected. The approach is based on using low-stringency sequence searches to identify divergent homologs. For receptors with multiple domains, the intersection of low-stringency searches can be used to identify divergent receptor sequences with high confidence. For multigene families, these predictions can be refined using sequence conservation among gene family paralogs. This strategy has recently been useful in identifying novel expansions in immune receptors in a number of animal genomes and will...</description>
            <author>Springer protocols feed by Immunology</author>
            <type>news</type>
        <comments>http://www.medworm.com/rss/comments.php?id=4969580</comments>
            <pubDate>Tue, 21 Jun 2011 23:00:00 +0100</pubDate>
            <guid isPermaLink="false">4969580</guid>        </item>
        <item>
            <title>Yeast Surface Display of Lamprey Variable Lymphocyte Receptors</title>
            <link>http://www.medworm.com/index.php?rid=4969579&amp;cid=s_37124_3_f&amp;fid=37124&amp;url=http%3A%2F%2Fwww.springerprotocols.com%2FAbstract%2Fdoi%2F10.1007%2F978-1-61779-139-0_2</link>
            <description>The variable lymphocyte receptors (VLRs) of lamprey and hagfish comprise leucine-rich repeat modules, instead of the immunoglobulin-like domain building blocks of antibodies and T-cell receptors in jawed vertebrates. Both types of vertebrate-rearranging antigen receptors are similarly diverse, with repertoires that can potentially exceed 1014 unique receptors. In order to characterize antigen-binding properties of the VLRs, we developed a high-throughput yeast surface display platform for the isolation of monoclonal VLRs. We have isolated VLRs that specifically bind hen egg lysozyme, &amp;beta;-galactosidase, cholera toxin subunit B, R-phycoerythrin, and the blood group trisaccharides A and B, with binding affinities in the mid-nanomolar to mid-picomolar range. VLRs may, thus, be excellent sin...</description>
            <author>Springer protocols feed by Immunology</author>
            <type>news</type>
        <comments>http://www.medworm.com/rss/comments.php?id=4969579</comments>
            <pubDate>Tue, 21 Jun 2011 23:00:00 +0100</pubDate>
            <guid isPermaLink="false">4969579</guid>        </item>
        <item>
            <title>Screening for Ligands of C-Type Lectin-Like Receptors</title>
            <link>http://www.medworm.com/index.php?rid=4969578&amp;cid=s_37124_3_f&amp;fid=37124&amp;url=http%3A%2F%2Fwww.springerprotocols.com%2FAbstract%2Fdoi%2F10.1007%2F978-1-61779-139-0_1</link>
            <description>In order to execute their immune functions, leukocytes interact with a broad range of cell types through cell surface receptors, such as those of the immunoglobulin and C-type lectin families, or indirectly through soluble factors. The characterization of activating and inhibitory counterparts of NK cell receptors on myeloid cells, as well as the identification of their physiological ligands, has provided new insights into the underlying mechanisms of immunity and homeostasis. Here, we describe methodology that can be employed to screen for endogenous ligands of type-II C-type lectin-like receptors using reporter cells and Fc fusion proteins. (Source: Springer protocols feed by Immunology)</description>
            <author>Springer protocols feed by Immunology</author>
            <type>news</type>
        <comments>http://www.medworm.com/rss/comments.php?id=4969578</comments>
            <pubDate>Tue, 21 Jun 2011 23:00:00 +0100</pubDate>
            <guid isPermaLink="false">4969578</guid>        </item>
        <item>
            <title>Identification of Scavenger Receptor Ligands</title>
            <link>http://www.medworm.com/index.php?rid=4969577&amp;cid=s_37124_3_f&amp;fid=37124&amp;url=http%3A%2F%2Fwww.springerprotocols.com%2FAbstract%2Fdoi%2F10.1007%2F978-1-61779-139-0_3</link>
            <description>Scavenger receptors (SRs) are structurally diverse but functionally related innate immune receptors involved in defence and clearance mechanisms. Their broad specificity relies on evolutionarily conserved pattern recognition domains which interact with a variety of microbial, apoptotic and modified self ligands. Studies of immune functions of SR-expressing cells require the identification of interaction partners for SRs. We have developed an ELISA-based method which allows for large-scale high-throughput screening of complex mixtures. The assay successfully identified bacterial and plasma ligands for macrophage scavenger receptor A and can be adapted to screen for novel exogenous or endogenous ligands for any immune receptor of interest. (Source: Springer protocols feed by Immunology)</description>
            <author>Springer protocols feed by Immunology</author>
            <type>news</type>
        <comments>http://www.medworm.com/rss/comments.php?id=4969577</comments>
            <pubDate>Tue, 21 Jun 2011 23:00:00 +0100</pubDate>
            <guid isPermaLink="false">4969577</guid>        </item>
        <item>
            <title>Flow Cytometric Detection of Human Regulatory T Cells</title>
            <link>http://www.medworm.com/index.php?rid=4442535&amp;cid=s_37124_3_f&amp;fid=37124&amp;url=http%3A%2F%2Fwww.springerprotocols.com%2FAbstract%2Fdoi%2F10.1007%2F978-1-61737-979-6_17</link>
            <description>Tregs are absolutely required for the maintenance of self tolerance in mouse and man. Major abnormalities in Treg number or function cause rare but fatal syndromes with autoimmune, allergic and inflammatory features. Whether subtle Treg abnormalities contribute to the pathogenesis of sporadic autoimmune, allergic and immunoinflammatory diseases in man remains controversial. Robust methods for identifying and isolating human Tregs in patients and healthy controls are essential if we are to understand their role in these increasingly common diseases. We have outlined below a flow cytometric technique to detect and isolate the entire human Treg population based on expression of CD4, CD25, and CD127. Use of a number of additional antibodies for defining subsets within the Treg compartment is d...</description>
            <author>Springer protocols feed by Immunology</author>
            <type>news</type>
        <comments>http://www.medworm.com/rss/comments.php?id=4442535</comments>
            <pubDate>Mon, 07 Feb 2011 14:55:50 +0100</pubDate>
            <guid isPermaLink="false">4442535</guid>        </item>
        <item>
            <title>Measurement of Proliferation and Disappearance of Regulatory T Cells in Human Studies Using Deuterium-Labeled Glucose</title>
            <link>http://www.medworm.com/index.php?rid=4442534&amp;cid=s_37124_3_f&amp;fid=37124&amp;url=http%3A%2F%2Fwww.springerprotocols.com%2FAbstract%2Fdoi%2F10.1007%2F978-1-61737-979-6_16</link>
            <description>The in vivo proliferation and disappearance kinetics of lymphocytes may be estimated in humans from rates of deuterium-labeled glucose (2H2-glucose) incorporation into DNA. This protocol describes its application to regulatory T cells (Treg). Because Treg divide frequently, 2H2-glucose is a suitable precursor, achieving high levels of enrichment over a short period. Being nonradioactive and readily administered, it is appropriate for human studies. (Source: Springer protocols feed by Immunology)</description>
            <author>Springer protocols feed by Immunology</author>
            <type>news</type>
        <comments>http://www.medworm.com/rss/comments.php?id=4442534</comments>
            <pubDate>Mon, 07 Feb 2011 14:55:50 +0100</pubDate>
            <guid isPermaLink="false">4442534</guid>        </item>
        <item>
            <title>Assessment of Suppressive Capacity by Human Regulatory T Cells Using a Reproducible, Bi-Directional CFSE-Based In Vitro Assay</title>
            <link>http://www.medworm.com/index.php?rid=4442533&amp;cid=s_37124_3_f&amp;fid=37124&amp;url=http%3A%2F%2Fwww.springerprotocols.com%2FAbstract%2Fdoi%2F10.1007%2F978-1-61737-979-6_15</link>
            <description>Regulatory T cells are involved in the maintenance of tolerance. Alterations in their functional capacity are implicated in the development of autoimmunity. In the case of common autoimmune disorders the defects in suppression may be partial, and may be due to a loss of Treg function, or a resistance to suppression by responder T cells. Thus in order to assess Treg function, an in vitro assay that is sensitive enough to demonstrate modest alterations in suppression, and which can differentiate between impaired suppression due to Treg dysfunction, and responder cell resistance is ideal. In this chapter we describe a CFSE based proliferation assay that utilizes a bead based activation system, which is reproducible, consistent and able to distinguish between defects in Treg function and the r...</description>
            <author>Springer protocols feed by Immunology</author>
            <type>news</type>
        <comments>http://www.medworm.com/rss/comments.php?id=4442533</comments>
            <pubDate>Mon, 07 Feb 2011 14:55:50 +0100</pubDate>
            <guid isPermaLink="false">4442533</guid>        </item>
        <item>
            <title>Depletion of Human Regulatory T Cells</title>
            <link>http://www.medworm.com/index.php?rid=4442532&amp;cid=s_37124_3_f&amp;fid=37124&amp;url=http%3A%2F%2Fwww.springerprotocols.com%2FAbstract%2Fdoi%2F10.1007%2F978-1-61737-979-6_14</link>
            <description>Regulatory T cells (Treg) have become increasingly relevant in the study of human disease including cancer. Treg cells have been shown to inhibit anti-tumor immune responses, and elevated Treg levels have been associated with certain types of cancer. Similarly, depletion of Tregs by various methods can also enhance anti-tumor immune responses. We have found a prevalence of Treg in cancer patients when compared to normal volunteers. In addition, we have shown that the depletion of Treg using the IL-2 fusion protein denileukin diftitox decreased Treg function and increased antigen-specific T cell response to a cancer vaccine. These results indicate the potential for combining Treg depletion with anti-cancer vaccines to enhance tumor antigen-specific immune responses and the need to explore t...</description>
            <author>Springer protocols feed by Immunology</author>
            <type>news</type>
        <comments>http://www.medworm.com/rss/comments.php?id=4442532</comments>
            <pubDate>Mon, 07 Feb 2011 14:55:50 +0100</pubDate>
            <guid isPermaLink="false">4442532</guid>        </item>
        <item>
            <title>Analysis of Human FOXP3+ Treg Cells Phenotype and Function</title>
            <link>http://www.medworm.com/index.php?rid=4442531&amp;cid=s_37124_3_f&amp;fid=37124&amp;url=http%3A%2F%2Fwww.springerprotocols.com%2FAbstract%2Fdoi%2F10.1007%2F978-1-61737-979-6_13</link>
            <description>Naturally occurring regulatory T (nT
         Reg
        ) cells play a critical role in the establishment of immunological self-tolerance in humans. Currently, the analysis of nT
         Reg
         cell function from bulk PBMC has led to discrepancies, largely due to the failure to discriminate T
         Reg
         cells from other antigen-experienced CD4+ T cells in states of inflammation. We developed a novel, multiparametric, single-cell strategy approach, which consists of isolating and expanding individual CD4+CD25+ T cells into clones, in turn allowing us to discriminate bona fide T
         Reg
         cells from activated, FOXP3+ T
         Eff
         cells, which frequently confound bulk CD25High T
         Reg
         functional assays. This approach enabled us to com...</description>
            <author>Springer protocols feed by Immunology</author>
            <type>news</type>
        <comments>http://www.medworm.com/rss/comments.php?id=4442531</comments>
            <pubDate>Mon, 07 Feb 2011 14:55:50 +0100</pubDate>
            <guid isPermaLink="false">4442531</guid>        </item>
        <item>
            <title>In Vivo Treg Suppression Assays</title>
            <link>http://www.medworm.com/index.php?rid=4442530&amp;cid=s_37124_3_f&amp;fid=37124&amp;url=http%3A%2F%2Fwww.springerprotocols.com%2FAbstract%2Fdoi%2F10.1007%2F978-1-61737-979-6_9</link>
            <description>We describe five in vivo models that examine the suppressive capacity of Tregs upon different target cell types. The advantages and disadvantages of each model including resources, time, and technical expertise required to execute each model are also described. (Source: Springer protocols feed by Immunology)</description>
            <author>Springer protocols feed by Immunology</author>
            <type>news</type>
        <comments>http://www.medworm.com/rss/comments.php?id=4442530</comments>
            <pubDate>Mon, 07 Feb 2011 14:55:50 +0100</pubDate>
            <guid isPermaLink="false">4442530</guid>        </item>
        <item>
            <title>Genetic Tools for Analysis of FoxP3+ Regulatory T Cells In Vivo</title>
            <link>http://www.medworm.com/index.php?rid=4442529&amp;cid=s_37124_3_f&amp;fid=37124&amp;url=http%3A%2F%2Fwww.springerprotocols.com%2FAbstract%2Fdoi%2F10.1007%2F978-1-61737-979-6_8</link>
            <description>The discovery of Foxp3 as a reliable marker for murine regulatory T cells has led to an explosion in the development of genetic tools for investigating the biology of regulatory T cells. More than 25 Foxp3-based mouse strains have been published with a variety of characteristics. The effects of Foxp3 expression can be analyzed using null, hypomorphic, conditional, altered control, and over-expression strains. Reporter strains are available to efficiently isolate Foxp3+ cells, with various reporter designs in terms of construct (fusion, replacement, and bicistronic positioning), and reporter system (GFP, YFP, RFP, Luciferase, Thy1.1). Multifunction strain fusion, replacement, and bicistronic positionings add functional proteins under the control of the Foxp3 promoter allowing induced apopto...</description>
            <author>Springer protocols feed by Immunology</author>
            <type>news</type>
        <comments>http://www.medworm.com/rss/comments.php?id=4442529</comments>
            <pubDate>Mon, 07 Feb 2011 14:55:50 +0100</pubDate>
            <guid isPermaLink="false">4442529</guid>        </item>
        <item>
            <title>In Vitro Expansion of Alloantigen-Specific Regulatory T Cells and Their Use in Prevention of Allograft Rejection</title>
            <link>http://www.medworm.com/index.php?rid=4442528&amp;cid=s_37124_3_f&amp;fid=37124&amp;url=http%3A%2F%2Fwww.springerprotocols.com%2FAbstract%2Fdoi%2F10.1007%2F978-1-61737-979-6_12</link>
            <description>Regulatory T lymphocytes expressing CD4, high levels of CD25, and the transcription factor Foxp3 play a crucial role in the control of immune responses to self and nonself antigens. In contrast to immunosuppressive drugs currently used to treat immunopathology, these cells act in a very specific manner. Consequently, their clinical potential in the treatment of autoimmune disorders, inflammatory diseases, graft-versus-host disease, and allograft rejection is currently extensively studied in experimental animal models as well as in clinical trials. We have previously shown that appropriately in vitro stimulated CD4+CD25high regulatory T cells can be used to prevent rejection of bone marrow, skin, and heart allografts in the Mouse. We here describe the protocols used in our laboratory to iso...</description>
            <author>Springer protocols feed by Immunology</author>
            <type>news</type>
        <comments>http://www.medworm.com/rss/comments.php?id=4442528</comments>
            <pubDate>Mon, 07 Feb 2011 14:55:50 +0100</pubDate>
            <guid isPermaLink="false">4442528</guid>        </item>
        <item>
            <title>Antigen-Specific Induction of Regulatory T Cells In Vivo and In Vitro</title>
            <link>http://www.medworm.com/index.php?rid=4442527&amp;cid=s_37124_3_f&amp;fid=37124&amp;url=http%3A%2F%2Fwww.springerprotocols.com%2FAbstract%2Fdoi%2F10.1007%2F978-1-61737-979-6_11</link>
            <description>The peripheral induction of Foxp3-expressing regulatory T cells outside the thymus is required in order to maintain local homeostasis in distinct microenvironments such as the gut. Extrathymic induction of Treg may also be exploited to prevent unwanted immune responses. Here, we discuss the methodology allowing for the stable de novo generation of Tregs specific for foreign antigens in peripheral lymphoid tissue via subimmunogenic peptide delivery using either peptide contained in fusion antibodies directed against the DEC205 endocytotic receptor on steady-state dendritic cells or the implantation of peptide-delivering osmotic mini-pumps. Furthermore, we also address methods in order to achieve TGF&amp;beta;-dependent Treg conversion in vitro, thereby mainly focusing on the role of retinoic ac...</description>
            <author>Springer protocols feed by Immunology</author>
            <type>news</type>
        <comments>http://www.medworm.com/rss/comments.php?id=4442527</comments>
            <pubDate>Mon, 07 Feb 2011 14:55:49 +0100</pubDate>
            <guid isPermaLink="false">4442527</guid>        </item>
        <item>
            <title>In Vivo Depletion of FoxP3+ Tregs Using the DEREG Mouse Model</title>
            <link>http://www.medworm.com/index.php?rid=4442526&amp;cid=s_37124_3_f&amp;fid=37124&amp;url=http%3A%2F%2Fwww.springerprotocols.com%2FAbstract%2Fdoi%2F10.1007%2F978-1-61737-979-6_10</link>
            <description>In recent years, researchers have increasingly focused on the modulation of regulatory T cell (Treg) function to interfere with the outcome of virtually every type of immune response. For a long time, specific in vivo targeting of Tregs was precluded due to the lack of appropriate markers. Only after the discovery of Foxp3 as a Treg-specific transcription factor, was the development of Treg-specific mouse models feasible. We generated DEREG mice (DEpletion of REGulatory T cells), a BAC (bacterial artificial chromosome) transgenic mouse line, which allows direct in vivo analysis and depletion of this exceedingly important cell type. Our DEREG mice carry a DTR-eGFP transgene under the control of an additional Foxp3 promoter, thereby allowing specific depletion of Treg by application of dipht...</description>
            <author>Springer protocols feed by Immunology</author>
            <type>news</type>
        <comments>http://www.medworm.com/rss/comments.php?id=4442526</comments>
            <pubDate>Mon, 07 Feb 2011 14:55:49 +0100</pubDate>
            <guid isPermaLink="false">4442526</guid>        </item>
        <item>
            <title>Live Imaging of Dendritic Cell&amp;ndash;Treg Cell Interactions</title>
            <link>http://www.medworm.com/index.php?rid=4442525&amp;cid=s_37124_3_f&amp;fid=37124&amp;url=http%3A%2F%2Fwww.springerprotocols.com%2FAbstract%2Fdoi%2F10.1007%2F978-1-61737-979-6_7</link>
            <description>The decision to launch an immune response is made during the interaction of helper T cells and regulatory T cells with dendritic cells. Recognition of antigen leads to formation of immunological synapses at the interface between the cells and to activation of the T cells. The length of interaction between the T cells and dendritic cells influences the functional outcome. We have shown that in the absence of proinflammatory stimuli, regulatory T cells and naive helper T cells interact differently with dendritic cells. Neuropilin-1, which is expressed by most regulatory T cells but not naive helper T cells, promotes prolonged interactions with immature dendritic cells, resulting in higher sensitivity to limiting amounts of antigen. We tracked T cell&amp;ndash;dendritic cell interactions in real-...</description>
            <author>Springer protocols feed by Immunology</author>
            <type>news</type>
        <comments>http://www.medworm.com/rss/comments.php?id=4442525</comments>
            <pubDate>Mon, 07 Feb 2011 14:55:49 +0100</pubDate>
            <guid isPermaLink="false">4442525</guid>        </item>
        <item>
            <title>ChIP-on-Chip for FoxP3</title>
            <link>http://www.medworm.com/index.php?rid=4442524&amp;cid=s_37124_3_f&amp;fid=37124&amp;url=http%3A%2F%2Fwww.springerprotocols.com%2FAbstract%2Fdoi%2F10.1007%2F978-1-61737-979-6_6</link>
            <description>Regulatory T (Treg) cells play a key role in dominant suppression of immune response and maintenance of immune homeostasis. Foxp3, a member of the forkhead transcription factor family, is indispensable for Treg cell development and function. Mice and human with Foxp3 mutations are severely impaired in Treg cell generation and develop lethal autoimmune diseases. We combined chromatin immuno-precipitation and mouse whole genome tiling array profiling (ChIP-on-Chip) to identify the direct downstream targets of Foxp3 in regulatory T cells. Our result showed that Foxp3 not only directly determines expression of a number of Treg signature molecules, but also regulates a group of transcription factors, which potentially control the expression of other Treg-specific genes. (Source: Springer protoc...</description>
            <author>Springer protocols feed by Immunology</author>
            <type>news</type>
        <comments>http://www.medworm.com/rss/comments.php?id=4442524</comments>
            <pubDate>Mon, 07 Feb 2011 14:55:48 +0100</pubDate>
            <guid isPermaLink="false">4442524</guid>        </item>
        <item>
            <title>Flow Cytometric Profiling of Mature and Developing Regulatory T Cells in the Thymus</title>
            <link>http://www.medworm.com/index.php?rid=4442523&amp;cid=s_37124_3_f&amp;fid=37124&amp;url=http%3A%2F%2Fwww.springerprotocols.com%2FAbstract%2Fdoi%2F10.1007%2F978-1-61737-979-6_5</link>
            <description>Natural Regulatory T (Treg) cells are a subset of CD4+ T cells characterized by expression of the transcription factor Foxp3 and the ability to suppress immune responses. Treg cells develop in the thymus in response to highly specific interactions between the T cell receptor (TCR) and self-antigens. These processes can be recapitulated in antigen-specific systems using transgenic mice that coexpress a TCR with its cognate peptide as a neoself-antigen. Here, we describe a method for using such a system to establish a flow cytometric profile of phenotype markers expressed by developing and mature Treg cells in the thymus. Our approach is to compare antigen-specific thymocytes developing in the presence or absence of Treg cell-selecting ligands to identify phenotypic changes that characterize...</description>
            <author>Springer protocols feed by Immunology</author>
            <type>news</type>
        <comments>http://www.medworm.com/rss/comments.php?id=4442523</comments>
            <pubDate>Mon, 07 Feb 2011 14:55:48 +0100</pubDate>
            <guid isPermaLink="false">4442523</guid>        </item>
        <item>
            <title>In Vitro and In Vivo Analyses of Regulatory T Cell Suppression of CD8+ T Cells</title>
            <link>http://www.medworm.com/index.php?rid=4442522&amp;cid=s_37124_3_f&amp;fid=37124&amp;url=http%3A%2F%2Fwww.springerprotocols.com%2FAbstract%2Fdoi%2F10.1007%2F978-1-61737-979-6_4</link>
            <description>The study of regulatory T cells (Treg) requires methods for both in vivo and in vitro analyses, both of which have different limitations, but which complement each other to give a more complete picture of physiological function than either method alone. Our analyses have focused on Treg-mediated suppression of CD8+ T cells, and in particular Tregs induced by viral infection. One of the unique characteristics of virus-induced Tregs is that they can suppress CD8+ T cell function in vitro without the requirement for additional stimulation. This ability correlates with their suppressive capacity and activated status in vivo. Interestingly, while virus-induced Tregs suppress CD8+ T cell function in vitro and in vivo, they do not suppress proliferation unless they are further activated in vitro....</description>
            <author>Springer protocols feed by Immunology</author>
            <type>news</type>
        <comments>http://www.medworm.com/rss/comments.php?id=4442522</comments>
            <pubDate>Mon, 07 Feb 2011 14:55:48 +0100</pubDate>
            <guid isPermaLink="false">4442522</guid>        </item>
        <item>
            <title>Generation of T Cell Hybridomas from Naturally Occurring FoxP3+ Regulatory T Cells</title>
            <link>http://www.medworm.com/index.php?rid=4442521&amp;cid=s_37124_3_f&amp;fid=37124&amp;url=http%3A%2F%2Fwww.springerprotocols.com%2FAbstract%2Fdoi%2F10.1007%2F978-1-61737-979-6_3</link>
            <description>Generation of regulatory T cells (or Treg) derived hybridomas offers a tool to study their antigen specificity. T cells hybridomas are produced by fusing TCR &amp;alpha;-&amp;beta;-thymoma BW5147 with highly dividing T cell population. In vitro anergy of Tregs is an obstacle in generation of highly dividing Treg population for their fusion. In this chapter, we describe a simple and efficient method to generate large number of blasting Treg and their successful fusion with thymoma BW5147. The resultant hybridomas lose Treg-specific transcription factor FoxP3, respond to antigenic stimulation by producing IL-2, and thus allow the evaluation of antigen specific, Tregs-derived TCRs. (Source: Springer protocols feed by Immunology)</description>
            <author>Springer protocols feed by Immunology</author>
            <type>news</type>
        <comments>http://www.medworm.com/rss/comments.php?id=4442521</comments>
            <pubDate>Mon, 07 Feb 2011 14:55:48 +0100</pubDate>
            <guid isPermaLink="false">4442521</guid>        </item>
        <item>
            <title>In Vitro Treg Suppression Assays</title>
            <link>http://www.medworm.com/index.php?rid=4442520&amp;cid=s_37124_3_f&amp;fid=37124&amp;url=http%3A%2F%2Fwww.springerprotocols.com%2FAbstract%2Fdoi%2F10.1007%2F978-1-61737-979-6_2</link>
            <description>Determining the activity of a regulatory T-cell population in vitro is often the first step in analyzing its function. To obtain reliable and reproducible results, it is critical to follow the protocol that is most applicable to your experimental question. We have outlined below a basic in vitro suppression assay as well as a variety of alternative/additional protocols that can be utilized alone or in combination as desired. (Source: Springer protocols feed by Immunology)</description>
            <author>Springer protocols feed by Immunology</author>
            <type>news</type>
        <comments>http://www.medworm.com/rss/comments.php?id=4442520</comments>
            <pubDate>Mon, 07 Feb 2011 14:55:48 +0100</pubDate>
            <guid isPermaLink="false">4442520</guid>        </item>
        <item>
            <title>Regulatory T Cells: History and Perspective</title>
            <link>http://www.medworm.com/index.php?rid=4442519&amp;cid=s_37124_3_f&amp;fid=37124&amp;url=http%3A%2F%2Fwww.springerprotocols.com%2FAbstract%2Fdoi%2F10.1007%2F978-1-61737-979-6_1</link>
            <description>Despite the skepticism that once prevailed among immunologists, it is now widely accepted that the normal immune system harbors a T-cell population, called regulatory T cells (Treg cells), specialized for immune suppression. It was first shown that depletion of a T-cell subpopulation from normal rodents produced autoimmune disease. Search for a molecular marker specific for such autoimmune-preventive Treg cells has revealed that the majority, if not all, of them constitutively express the CD25 molecule as depletion of CD25+CD4+ T cells spontaneously evokes autoimmune disease in otherwise normal rodents. The expression of CD25 by Treg cells has made it possible to delineate their developmental pathways, in particular their thymic development, and establish simple in vitro assay for assessin...</description>
            <author>Springer protocols feed by Immunology</author>
            <type>news</type>
        <comments>http://www.medworm.com/rss/comments.php?id=4442519</comments>
            <pubDate>Mon, 07 Feb 2011 14:55:48 +0100</pubDate>
            <guid isPermaLink="false">4442519</guid>        </item>
        <item>
            <title>Immunology of Vaccine Adjuvants</title>
            <link>http://www.medworm.com/index.php?rid=4310102&amp;cid=s_37124_3_f&amp;fid=37124&amp;url=http%3A%2F%2Fwww.springerprotocols.com%2FAbstract%2Fdoi%2F10.1007%2F978-1-60761-585-9_1</link>
            <description>In recent times vaccine adjuvants, or immunopotentiators, received abundant attention in the media as critical ingredients of current and future vaccines. Indeed, vaccine adjuvants are recognized to make the difference between competing vaccines based on identical antigens. Moreover, it is recognized that vaccines designed for certain indications require a matching combination of selected antigen(s) together with a critical immunopotentiator that selectively drives the required immune pathway with minimal adverse reactions. Recently, the mechanistic actions of some immunopotentiators have become clearer as a result of research focused on innate immunity receptors. These insights enable more rational adjuvant and vaccine design, which, ideally, is based on predictable immunophenotypes follo...</description>
            <author>Springer protocols feed by Immunology</author>
            <type>news</type>
        <comments>http://www.medworm.com/rss/comments.php?id=4310102</comments>
            <pubDate>Sat, 01 May 2010 00:00:00 +0100</pubDate>
            <guid isPermaLink="false">4310102</guid>        </item>
        <item>
            <title>Nonclinical Safety Assessment of Vaccines and Adjuvants</title>
            <link>http://www.medworm.com/index.php?rid=4310101&amp;cid=s_37124_3_f&amp;fid=37124&amp;url=http%3A%2F%2Fwww.springerprotocols.com%2FAbstract%2Fdoi%2F10.1007%2F978-1-60761-585-9_3</link>
            <description>To ensure the safe administration of vaccines to humans, vaccines (just like any new chemical entity) are evaluated in a series of nonclinical safety assessment studies that aim at identifying the potential toxicities associated with their administration. The nonclinical safety assessment of vaccines, however, is only part of a testing battery performed prior to human administration, which includes (1) the evaluation of the vaccine in efficacy and immunogenicity studies in animal models, (2) a quality control testing program, and (3) toxicology (nonclinical safety assessment) testing in relevant animal models. Although each of these evaluations plays a critical role in ensuring vaccine safety, the nonclinical safety assessment is the most relevant to the evaluation in human clinical trials...</description>
            <author>Springer protocols feed by Immunology</author>
            <type>news</type>
        <comments>http://www.medworm.com/rss/comments.php?id=4310101</comments>
            <pubDate>Sat, 01 May 2010 00:00:00 +0100</pubDate>
            <guid isPermaLink="false">4310101</guid>        </item>
        <item>
            <title>Evaluation of Targets for Ovarian Cancer Gene Silencing Therapy: In Vitro and In Vivo Approaches</title>
            <link>http://www.medworm.com/index.php?rid=4305185&amp;cid=s_37124_3_f&amp;fid=37124&amp;url=http%3A%2F%2Fwww.springerprotocols.com%2FAbstract%2Fdoi%2F10.1007%2F978-1-60761-588-0_27</link>
            <description>Ovarian cancer is the most lethal neoplasm of the female genital tract. Despite progress with chemotherapy, surgery and supportive care, the death rate remains extremely high. Gene silencing therapy represents a possible opportunity to advance the management of ovarian cancer patients. The concept of gene silencing therapy, which is based on RNA interference (RNAi) phenomenon, requires selection of targeted genes and development of a strategy for genetic drug development. Recently, plenty of research studies in ovarian cancer genetics have been published. Although they can be analyzed regarding candidate gene selection, the therapeutic effect of particular gene silencing can only be evaluated experimentally at this time. Obviously, the correct choice and application of a genetic drug deliv...</description>
            <author>Springer protocols feed by Immunology</author>
            <type>news</type>
        <comments>http://www.medworm.com/rss/comments.php?id=4305185</comments>
            <pubDate>Sat, 01 May 2010 00:00:00 +0100</pubDate>
            <guid isPermaLink="false">4305185</guid>        </item>
        <item>
            <title>A Potential Therapeutic for Pandemic Influenza Using RNA Interference</title>
            <link>http://www.medworm.com/index.php?rid=4305184&amp;cid=s_37124_3_f&amp;fid=37124&amp;url=http%3A%2F%2Fwww.springerprotocols.com%2FAbstract%2Fdoi%2F10.1007%2F978-1-60761-588-0_26</link>
            <description>RNA interference (RNAi) involves sequence-specific downregulation of target genes, leading to gene silencing in vitro and in vivo. Synthetic small interfering RNAs (siRNAs), formulated with appropriate delivery agents, can serve as effective tools for RNAi-based therapeutics. The potential of siRNA to provide antiviral activity has been studied extensively in many respiratory viruses, including influenza virus, wherein specific siRNAs target highly-conserved regions of influenza viral genome, leading to potent inhibition of viral RNA replication. Despite various delivery strategies, such as polycations and liposomes that have been employed to formulate siRNAs, effective delivery modalities are still needed. Although current strategies can provide significant biodistribution and delivery in...</description>
            <author>Springer protocols feed by Immunology</author>
            <type>news</type>
        <comments>http://www.medworm.com/rss/comments.php?id=4305184</comments>
            <pubDate>Sat, 01 May 2010 00:00:00 +0100</pubDate>
            <guid isPermaLink="false">4305184</guid>        </item>
        <item>
            <title>Direct Application of siRNA for In Vivo Pain Research</title>
            <link>http://www.medworm.com/index.php?rid=3426003&amp;cid=s_37124_3_f&amp;fid=37124&amp;url=http%3A%2F%2Fwww.springerprotocols.com%2FAbstract%2Fdoi%2F10.1007%2F978-1-60761-588-0_25</link>
            <description>Pain is the new burden of the twenty-first century, raising enormous socio-economic costs to developed and underdeveloped countries. Chronic pain is a central nervous system (CNS) pathology, affecting a large proportion of the population. Morphine and its derivatives are still the golden clinical standards for treating pain although they induce severe side effects. To this day, we still have poor understanding of nociceptive pain and its underlying complex mechanisms; furthermore, novelty in clinical analgesics is lacking. (Source: Springer protocols feed by Immunology)</description>
            <author>Springer protocols feed by Immunology</author>
            <type>news</type>
        <comments>http://www.medworm.com/rss/comments.php?id=3426003</comments>
            <pubDate>Thu, 01 Apr 2010 12:39:21 +0100</pubDate>
            <guid isPermaLink="false">3426003</guid>        </item>
        <item>
            <title>Topical Application of siRNA Targeting Cutaneous Dendritic Cells in Allergic Skin Disease</title>
            <link>http://www.medworm.com/index.php?rid=3426002&amp;cid=s_37124_3_f&amp;fid=37124&amp;url=http%3A%2F%2Fwww.springerprotocols.com%2FAbstract%2Fdoi%2F10.1007%2F978-1-60761-588-0_24</link>
            <description>RNA interference is a promising method for silencing specific genes and has great potential for therapeutic applications. However, the major hurdle for therapeutic application is the limited stability of double-strand RNA (dsRNA) and the absence of a reliable delivery method to target cells. Skin appears to be a favorable target for small interfering RNA (siRNA) therapy. Dendritic cells (DCs) exist in the skin and mucosae on the front lines of defense; these cells capture antigens and play a crucial role in inducing immunity and tolerance. (Source: Springer protocols feed by Immunology)</description>
            <author>Springer protocols feed by Immunology</author>
            <type>news</type>
        <comments>http://www.medworm.com/rss/comments.php?id=3426002</comments>
            <pubDate>Thu, 01 Apr 2010 12:39:21 +0100</pubDate>
            <guid isPermaLink="false">3426002</guid>        </item>
        <item>
            <title>Preventing Immune Rejection Through Gene Silencing</title>
            <link>http://www.medworm.com/index.php?rid=3426001&amp;cid=s_37124_3_f&amp;fid=37124&amp;url=http%3A%2F%2Fwww.springerprotocols.com%2FAbstract%2Fdoi%2F10.1007%2F978-1-60761-588-0_23</link>
            <description>Dendritic cells (DCs) comprise a family of professional antigen-presenting cells responsible for the induction of primary immune responses. DCs are also important for the induction of immunological tolerance. Recent research has revealed that DC maturation is associated with activation of the NF-&amp;kappa;B pathway. RelB, one of the five families of Rel proteins involved in the NF-&amp;kappa;B pathway, plays a critical role in coordinating the terminal stages of DC maturation and has the ability to induce optimal Th1 T cell responses. DCs generated from mouse bone marrow can be silenced using siRNA specific for the target gene. Silencing RelB in DCs will result in the generation of immunoregulatory dendritic cells that inhibit allogenic T cell responses. The KLH-specific T cell response should al...</description>
            <author>Springer protocols feed by Immunology</author>
            <type>news</type>
        <comments>http://www.medworm.com/rss/comments.php?id=3426001</comments>
            <pubDate>Thu, 01 Apr 2010 12:39:21 +0100</pubDate>
            <guid isPermaLink="false">3426001</guid>        </item>
        <item>
            <title>Preventing Tissue Injury Using siRNA</title>
            <link>http://www.medworm.com/index.php?rid=3426000&amp;cid=s_37124_3_f&amp;fid=37124&amp;url=http%3A%2F%2Fwww.springerprotocols.com%2FAbstract%2Fdoi%2F10.1007%2F978-1-60761-588-0_22</link>
            <description>RNA interference (RNAi) is a process through which double-stranded RNA induces the activation of endogenous cellular pathways of RNA degradation, resulting in selective and potent silencing of genes that have homology to the double strand. Much of the excitement surrounding small interfering RNA (siRNA)-mediated therapeutics arises from the fact that this approach overcomes many of the shortcomings previously experienced with alternative approaches to selective blocking that use antibodies, antisense oligonucleotides or pharmacological inhibitors. Induction of RNAi through administration of siRNA has been successfully applied to the treatment of hepatitis, viral infections, and cancer. Increased success in addressing issues of siRNA delivery and efficiency will permit this approach to evol...</description>
            <author>Springer protocols feed by Immunology</author>
            <type>news</type>
        <comments>http://www.medworm.com/rss/comments.php?id=3426000</comments>
            <pubDate>Thu, 01 Apr 2010 12:39:21 +0100</pubDate>
            <guid isPermaLink="false">3426000</guid>        </item>
        <item>
            <title>Inhibitory RNA Molecules in Immunotherapy for Cancer</title>
            <link>http://www.medworm.com/index.php?rid=3425999&amp;cid=s_37124_3_f&amp;fid=37124&amp;url=http%3A%2F%2Fwww.springerprotocols.com%2FAbstract%2Fdoi%2F10.1007%2F978-1-60761-588-0_21</link>
            <description>Over the past few decades, our expanding knowledge of the mammalian immune system - how it is developed, activated, and regulated - has fostered hope that it may be harnessed in the future to successfully treat human cancer. The immune system activated by cancer vaccines may have the unique ability to selectively eradicate tumor cells at multiple sites in the body without inflicting damage on normal tissue. However, progress in the development of cancer vaccines that effectively capitalize on this ability has been limited and slow. The immune system is restrained by complex, negative feedback mechanisms that evolved to protect the host against autoimmunity and may also prevent antitumor immunity. In addition, tumor cells exploit a plethora of strategies to evade detection and elimination b...</description>
            <author>Springer protocols feed by Immunology</author>
            <type>news</type>
        <comments>http://www.medworm.com/rss/comments.php?id=3425999</comments>
            <pubDate>Thu, 01 Apr 2010 12:39:20 +0100</pubDate>
            <guid isPermaLink="false">3425999</guid>        </item>
        <item>
            <title>A New Approach for Therapeutic Use by RNA Interference in the Brain</title>
            <link>http://www.medworm.com/index.php?rid=3425998&amp;cid=s_37124_3_f&amp;fid=37124&amp;url=http%3A%2F%2Fwww.springerprotocols.com%2FAbstract%2Fdoi%2F10.1007%2F978-1-60761-588-0_20</link>
            <description>RNA interference (RNAi) is a gene silencing phenomenon that is induced by ribonucleoprotein complexes containing 21-28 nucleotides (nt) of double-stranded RNA (si/miRNA). Although this phenomenon occurs in an inherent manner, it can also be induced in an artificially manipulated manner. Recently, the understanding of RNAi mechanisms has progressed from that in plants to that in mammals. As RNAi is a highly efficient and readily available procedure to knockdown specific targets, it can possibly be used as a new technique providing many researchers and clinicians with opportunities for its experimental use and prospective clinical application. Consequently, there has been a rush of elucidation of the effective sequences of siRNAs used for the knockdown of the targets in many fields, includin...</description>
            <author>Springer protocols feed by Immunology</author>
            <type>news</type>
        <comments>http://www.medworm.com/rss/comments.php?id=3425998</comments>
            <pubDate>Thu, 01 Apr 2010 12:39:20 +0100</pubDate>
            <guid isPermaLink="false">3425998</guid>        </item>
        <item>
            <title>Transfection of siRNAs in Multiple Myeloma Cell Lines</title>
            <link>http://www.medworm.com/index.php?rid=3425997&amp;cid=s_37124_3_f&amp;fid=37124&amp;url=http%3A%2F%2Fwww.springerprotocols.com%2FAbstract%2Fdoi%2F10.1007%2F978-1-60761-588-0_19</link>
            <description>RNA interference (RNAi), a valuable tool to specifically silence gene expression, is becoming an indispensable weapon in the arsenal of functional genomics, target validation and gene-specific therapeutic research. We have shown that Streptolysin-O (SLO) reversible permeabilization is an efficient method to deliver small interfering RNAs (siRNAs) to hard-to-transfect human myeloma cell lines. In addition, we have shown that transfection of siRNAs, using the SLO reversible permeabilization, specifically and efficiently induces gene silencing in myeloma cell lines. (Source: Springer protocols feed by Immunology)</description>
            <author>Springer protocols feed by Immunology</author>
            <type>news</type>
        <comments>http://www.medworm.com/rss/comments.php?id=3425997</comments>
            <pubDate>Thu, 01 Apr 2010 12:39:20 +0100</pubDate>
            <guid isPermaLink="false">3425997</guid>        </item>
        <item>
            <title>Polyethylenimine (PEI)/siRNA-Mediated Gene Knockdown In Vitro and In Vivo</title>
            <link>http://www.medworm.com/index.php?rid=3425996&amp;cid=s_37124_3_f&amp;fid=37124&amp;url=http%3A%2F%2Fwww.springerprotocols.com%2FAbstract%2Fdoi%2F10.1007%2F978-1-60761-588-0_18</link>
            <description>Since its discovery about 10 years ago, RNA interference (RNAi) has become an almost standard method for the knockdown of any target gene of interest. It is mediated by small interfering RNAs (siRNAs), which trigger a catalytic mechanism for mRNA degradation. Consequently, the delivery of intact siRNA is of critical importance for the induction of RNAi. Due to the physicochemical and biological properties of siRNAs, resulting in high instability and poor cellular uptake, siRNA modifications and pharmaceutical formulations have been used to enhance RNAi efficacy. This is particularly relevant for the in vivo delivery of siRNAs, which still poses a major hurdle for the experimental or therapeutic application of RNAi. (Source: Springer protocols feed by Immunology)</description>
            <author>Springer protocols feed by Immunology</author>
            <type>news</type>
        <comments>http://www.medworm.com/rss/comments.php?id=3425996</comments>
            <pubDate>Thu, 01 Apr 2010 12:39:20 +0100</pubDate>
            <guid isPermaLink="false">3425996</guid>        </item>
        <item>
            <title>Cellular siRNA Delivery Using TatU1A and Photo-Induced RNA Interference</title>
            <link>http://www.medworm.com/index.php?rid=3425995&amp;cid=s_37124_3_f&amp;fid=37124&amp;url=http%3A%2F%2Fwww.springerprotocols.com%2FAbstract%2Fdoi%2F10.1007%2F978-1-60761-588-0_17</link>
            <description>RNA interference (RNAi)-mediated silencing of specific genes represents a powerful tool for analyzing protein function. It also has profound biotechnological applications for cellular engineering and therapeutics. However, it is necessary to have a method that controls RNAi in response to artificially regulated stimulation. We designed a fluorescently labeled carrier protein to deliver short hairpin RNA (shRNA) with activity that could be regulated via photostimulation. We constructed a cell-permeable RNA-binding protein (RBP) by fusing the U1A RBP and a HIV-1 Tat peptide, which was labeled with an Alexa Fluor 546 fluorophore (TatU1A-Alexa). TatU1A-Alexa bound specifically to shRNA, which contains a U1A-binding sequence. The TatU1A-Alexa/shRNA complex was then internalized into cells via a...</description>
            <author>Springer protocols feed by Immunology</author>
            <type>news</type>
        <comments>http://www.medworm.com/rss/comments.php?id=3425995</comments>
            <pubDate>Thu, 01 Apr 2010 12:39:20 +0100</pubDate>
            <guid isPermaLink="false">3425995</guid>        </item>
        <item>
            <title>Biodegradable Polymer-Mediated sh/siRNA Delivery for Cancer Studies</title>
            <link>http://www.medworm.com/index.php?rid=3425994&amp;cid=s_37124_3_f&amp;fid=37124&amp;url=http%3A%2F%2Fwww.springerprotocols.com%2FAbstract%2Fdoi%2F10.1007%2F978-1-60761-588-0_16</link>
            <description>Discovery of RNA interference (RNAi)-mediated specific gene silencing has raised hope for cancer therapy. Unfortunately, the execution of RNAi by delivering small-interfering RNA (siRNA) or small hairpin RNA (shRNA) remains a prime challenge. A methodical evaluation of cationic polymers in RNAi-based cancer studies may offer a promising solution to this problem. In this chapter, we report the methodologies for comprehensive characterization of a biodegradable polymeric system for sh/siRNA delivery in cancer studies. The chapter will describe synthesis, characterization, and optimization of biodegradable poly (&amp;beta;-amino ester) for sh/siRNA delivery. The protocols are provided for shRNA and siRNA complex preparation, stability and morphology study. Also, detailed methods are provided for ...</description>
            <author>Springer protocols feed by Immunology</author>
            <type>news</type>
        <comments>http://www.medworm.com/rss/comments.php?id=3425994</comments>
            <pubDate>Thu, 01 Apr 2010 12:39:20 +0100</pubDate>
            <guid isPermaLink="false">3425994</guid>        </item>
        <item>
            <title>Using siRNA to Uncover Novel Oncogenic Signaling Pathways</title>
            <link>http://www.medworm.com/index.php?rid=3425993&amp;cid=s_37124_3_f&amp;fid=37124&amp;url=http%3A%2F%2Fwww.springerprotocols.com%2FAbstract%2Fdoi%2F10.1007%2F978-1-60761-588-0_15</link>
            <description>Tumor invasion and metastasis are the primary causes of cancer patient mortality, underscoring the need for identification of novel genes and signaling pathways that mediate these prognosis-determining phenomena. To identify and characterize novel lung adenocarcinoma genes associated with lung cancer progression, we created a bioinformatics-based approach that focuses on human cell-cycle-regulated genes that have evolved only in higher organisms but not in lower eukaryotic cells. In siRNA experiments in lung cancer cells, FLJ10540 was identified as one of several novel targets involved in cell migration and invasion. Here, we demonstrate that PI3K inhibition affects FLJ10540-mediated cell migration and invasion and further, that FLJ10540 knockdown ablates AKT-Ser473 phosphorylation. Taken ...</description>
            <author>Springer protocols feed by Immunology</author>
            <type>news</type>
        <comments>http://www.medworm.com/rss/comments.php?id=3425993</comments>
            <pubDate>Thu, 01 Apr 2010 12:39:20 +0100</pubDate>
            <guid isPermaLink="false">3425993</guid>        </item>
        <item>
            <title>Nonviral siRNA Delivery for Gene Silencing in Neurodegenerative Diseases</title>
            <link>http://www.medworm.com/index.php?rid=3425992&amp;cid=s_37124_3_f&amp;fid=37124&amp;url=http%3A%2F%2Fwww.springerprotocols.com%2FAbstract%2Fdoi%2F10.1007%2F978-1-60761-588-0_14</link>
            <description>Linking genes with the underlying mechanisms of diseases is one of the biggest challenges of genomics-driven drug discovery research. Designing an inhibitor for any neurodegenerative disease that effectively halts the pathogenicity of the disease is yet to be achieved. The challenge lies in crossing the blood-brain barrier (BBB)/blood-cerebrospinal fluid barrier (BCSFB) to reach the catalytic pockets of the enzyme/protein involved in the molecular mechanism of the disease process. Designing siRNA with exquisite specificity may result in selective suppression of the disease-linked gene. Although siRNA is the most promising method, it loses its potency in downregulating the gene due to its inherent instability, off-target effects, and lack of on-target effective delivery systems. Viral as we...</description>
            <author>Springer protocols feed by Immunology</author>
            <type>news</type>
        <comments>http://www.medworm.com/rss/comments.php?id=3425992</comments>
            <pubDate>Thu, 01 Apr 2010 12:39:20 +0100</pubDate>
            <guid isPermaLink="false">3425992</guid>        </item>
        <item>
            <title>New Methods for Reverse Transfection with siRNA from a Solid Surface</title>
            <link>http://www.medworm.com/index.php?rid=3425991&amp;cid=s_37124_3_f&amp;fid=37124&amp;url=http%3A%2F%2Fwww.springerprotocols.com%2FAbstract%2Fdoi%2F10.1007%2F978-1-60761-588-0_13</link>
            <description>We describe two efficient and inexpensive methods for reverse transfection with siRNA from a solid surface. One method involves localized reverse transfection from spots on a glass slide, which is mainly useful for making &amp;ldquo;transfection microarrays&amp;rdquo; (TMAs). The other involves reverse transfection in multiple wells of microtiter plates. Conditions for cell culture, preparation of reagents, and details of reverse transfection have been determined for several lines of cells, but we focus here on experiments with HeLa cells. In particular, we evaluated the efficiency of transfection, the cytotoxic effects of reverse transfection, and the efficiency of gene &amp;ldquo;knockdown&amp;rdquo; by transfection. We also performed phenotypic screening for a functional gene, during which cell viabili...</description>
            <author>Springer protocols feed by Immunology</author>
            <type>news</type>
        <comments>http://www.medworm.com/rss/comments.php?id=3425991</comments>
            <pubDate>Thu, 01 Apr 2010 12:39:19 +0100</pubDate>
            <guid isPermaLink="false">3425991</guid>        </item>
        <item>
            <title>Hydrodynamic Delivery Protocols</title>
            <link>http://www.medworm.com/index.php?rid=3425990&amp;cid=s_37124_3_f&amp;fid=37124&amp;url=http%3A%2F%2Fwww.springerprotocols.com%2FAbstract%2Fdoi%2F10.1007%2F978-1-60761-588-0_12</link>
            <description>We describe the use of hydrodynamic administration as a technique to deliver naked siRNA constructs into experimental animals as a method of transient gene knockdown. This approach demonstrates that RNAi can be used to silence endogenous genes, involved in the cause of human diseases, with a clinically acceptable formulation and route of administration. (Source: Springer protocols feed by Immunology)</description>
            <author>Springer protocols feed by Immunology</author>
            <type>news</type>
        <comments>http://www.medworm.com/rss/comments.php?id=3425990</comments>
            <pubDate>Thu, 01 Apr 2010 12:39:19 +0100</pubDate>
            <guid isPermaLink="false">3425990</guid>        </item>
        <item>
            <title>siRNA Specific Delivery System for Targeting Dendritic Cells</title>
            <link>http://www.medworm.com/index.php?rid=3425989&amp;cid=s_37124_3_f&amp;fid=37124&amp;url=http%3A%2F%2Fwww.springerprotocols.com%2FAbstract%2Fdoi%2F10.1007%2F978-1-60761-588-0_11</link>
            <description>siRNA therapy offers immense potential for clinical application. Under physiological conditions, however, siRNA was demonstrated to have a short half-life. Additionally, it may also cause ubiquitous gene silencing as it does not possess a tissue-specific homing mechanism. Thus, the rate-limiting step in the emergence of siRNA as a potential therapeutic agent is the current lack of a safe and tissue- or cell-specific in vivo delivery system. Herein, we propose a novel, cell-specific method for the in vivo delivery of siRNA to dendritic cells (DCs) with the purpose of inducing immune modulation. CD40 siRNA was incorporated within the interior of 86 nm liposomes, which were decorated with surface-bound mAb NLDC-145 as a targeting mechanism. The siRNA encapsulation efficiency was determined to...</description>
            <author>Springer protocols feed by Immunology</author>
            <type>news</type>
        <comments>http://www.medworm.com/rss/comments.php?id=3425989</comments>
            <pubDate>Thu, 01 Apr 2010 12:39:19 +0100</pubDate>
            <guid isPermaLink="false">3425989</guid>        </item>
        <item>
            <title>Designing Optimal siRNA Based on Target Site Accessibility</title>
            <link>http://www.medworm.com/index.php?rid=3425988&amp;cid=s_37124_3_f&amp;fid=37124&amp;url=http%3A%2F%2Fwww.springerprotocols.com%2FAbstract%2Fdoi%2F10.1007%2F978-1-60761-588-0_9</link>
            <description>RNA interference, mediated by small interfering RNAs (siRNAs), is a powerful tool for investigation of gene functions and it is increasingly being used as a therapeutic agent. However, not all siRNAs are equally potent - although simple rules for the selection of good siRNAs were proposed early on, siRNAs are still plagued with widely fluctuating efficiency. Recently, new design tools that incorporate both the structural features of the targeted RNAs and the sequence features of the siRNAs have substantially improved the efficacy of siRNAs. In this chapter, we present the algorithms behind these accessibility-aided tools and show how to design efficient siRNAs with their help. (Source: Springer protocols feed by Immunology)</description>
            <author>Springer protocols feed by Immunology</author>
            <type>news</type>
        <comments>http://www.medworm.com/rss/comments.php?id=3425988</comments>
            <pubDate>Thu, 01 Apr 2010 12:39:19 +0100</pubDate>
            <guid isPermaLink="false">3425988</guid>        </item>
        <item>
            <title>Strategies in Designing Multigene Expression Units to Downregulate HIV-1</title>
            <link>http://www.medworm.com/index.php?rid=3425987&amp;cid=s_37124_3_f&amp;fid=37124&amp;url=http%3A%2F%2Fwww.springerprotocols.com%2FAbstract%2Fdoi%2F10.1007%2F978-1-60761-588-0_8</link>
            <description>The treatment of viral diseases such as HIV and HCV is limited by the genetic diversity of the viruses, especially when they are under the selective pressure of drugs. This problem holds true for gene-based therapies using RNAi in which there is evolution of drug-resistant strains under the discriminating pressure of treatment (1, 2). In a gene therapy setting for treatment of HIV, the incorporation of multiple effector molecules, targeting different viral and cellular sequences, can improve viral inhibition by substantially delaying the emergence of escape mutants (3-8). However, for short hairpin RNA triggers of RNAi, high levels of expression by strong Pol III promoters has led to cell toxicity, and even death in experimental animals (9, 10). Here, we describe a new combinatorial anti-H...</description>
            <author>Springer protocols feed by Immunology</author>
            <type>news</type>
        <comments>http://www.medworm.com/rss/comments.php?id=3425987</comments>
            <pubDate>Thu, 01 Apr 2010 12:39:19 +0100</pubDate>
            <guid isPermaLink="false">3425987</guid>        </item>
        <item>
            <title>Optimized Gene Silencing by Co-expression of Multiple shRNAs in a Single Vector</title>
            <link>http://www.medworm.com/index.php?rid=3425986&amp;cid=s_37124_3_f&amp;fid=37124&amp;url=http%3A%2F%2Fwww.springerprotocols.com%2FAbstract%2Fdoi%2F10.1007%2F978-1-60761-588-0_7</link>
            <description>Currently, RNA interference technology is one of the most powerful tools in molecular biology and has been widely used in genetic manipulation. In addition to chemically synthesized small interfering RNA (siRNA), vector-based methods have been developed for stable gene silencing by the expression of a single short-hairpin RNA (shRNA). The artificially expressed RNA molecules are processed to form a silencing complex that causes the specific degradation of its target mRNA. However, silencing vectors containing a single shRNA-expressing sequence sometimes induce only poor knockdown. In order to improve the knockdown efficiency using shRNA, the multiple shRNA-expressing sequences were introduced into a single plasmid vector. Compared with the conventional single shRNA-expression vector, the m...</description>
            <author>Springer protocols feed by Immunology</author>
            <type>news</type>
        <comments>http://www.medworm.com/rss/comments.php?id=3425986</comments>
            <pubDate>Thu, 01 Apr 2010 12:39:19 +0100</pubDate>
            <guid isPermaLink="false">3425986</guid>        </item>
        <item>
            <title>Bioinformatic Approaches to siRNA Selection and Optimization</title>
            <link>http://www.medworm.com/index.php?rid=3425985&amp;cid=s_37124_3_f&amp;fid=37124&amp;url=http%3A%2F%2Fwww.springerprotocols.com%2FAbstract%2Fdoi%2F10.1007%2F978-1-60761-588-0_6</link>
            <description>RNA interference mediated by short interfering RNA (siRNA) molecules represents a powerful genetic tool with an increasing interest as potential therapeutics. Current bioinformatic approaches to design functional siRNA molecules take into account both empirical and rational approaches to identify selectable characteristics of active and specific siRNA molecules and focusing the downstream events in the RNAi pathway, such as target messenger RNA accessibility. The design of effective siRNA molecules is the key to successful experimentation with RNAi. Here, we show advanced siRNA design parameters and options for highly efficient siRNA candidate search. (Source: Springer protocols feed by Immunology)</description>
            <author>Springer protocols feed by Immunology</author>
            <type>news</type>
        <comments>http://www.medworm.com/rss/comments.php?id=3425985</comments>
            <pubDate>Thu, 01 Apr 2010 12:39:19 +0100</pubDate>
            <guid isPermaLink="false">3425985</guid>        </item>
        <item>
            <title>Computational siRNA Design Considering Alternative Splicing</title>
            <link>http://www.medworm.com/index.php?rid=3351367&amp;cid=s_37124_3_f&amp;fid=37124&amp;url=http%3A%2F%2Fwww.springerprotocols.com%2FAbstract%2Fdoi%2F10.1007%2F978-1-60761-588-0_5</link>
            <description>RNA interference (RNAi) with small interfering RNA (siRNA) has become a powerful tool in functional and medical genomic research through directed post-transcriptional gene silencing. In order to apply RNAi technique to eukaryotic organisms, where frequent alternative splicing results in diversification of mRNAs and finally of proteins, we need spliced mRNA isoform silencing to study the function of individual proteins. AsiDesigner is a web-based siRNA design software system, which provides siRNA design capability to account for alternative splicing in mRNA level gene silencing. It provides numerous novel functions, including designing common siRNAs for the silencing of more than two mRNAs simultaneously, a scoring scheme to evaluate the performance of designed siRNAs by adopting state-of-t...</description>
            <author>Springer protocols feed by Immunology</author>
            <type>news</type>
        <comments>http://www.medworm.com/rss/comments.php?id=3351367</comments>
            <pubDate>Thu, 11 Mar 2010 13:39:06 +0100</pubDate>
            <guid isPermaLink="false">3351367</guid>        </item>
        <item>
            <title>Allele-Specific Silencing by RNA Interference</title>
            <link>http://www.medworm.com/index.php?rid=3351366&amp;cid=s_37124_3_f&amp;fid=37124&amp;url=http%3A%2F%2Fwww.springerprotocols.com%2FAbstract%2Fdoi%2F10.1007%2F978-1-60761-588-0_4</link>
            <description>Allele-specific gene silencing by RNA interference (RNAi) is therapeutically useful for specifically inhibiting the expression of disease-associated alleles without suppressing the expression of corresponding wild-type alleles. To realize such allele-specific RNAi (ASP-RNAi), the design and assessment of small interfering RNA (siRNA) duplexes conferring ASP-RNAi is vital; however, it is also difficult. We have developed an assay system with reporter alleles that encode the Photinus and Renilla luciferase genes carrying mutant and wild-type allelic sequences in their 3&amp;prime;-untranslated regions. The assay system allows us to evaluate designed siRNAs and also short hairpin RNAs for allele-specific silencing against target mutant alleles as well as off-target silencing against corresponding...</description>
            <author>Springer protocols feed by Immunology</author>
            <type>news</type>
        <comments>http://www.medworm.com/rss/comments.php?id=3351366</comments>
            <pubDate>Thu, 11 Mar 2010 13:39:06 +0100</pubDate>
            <guid isPermaLink="false">3351366</guid>        </item>
        <item>
            <title>Current Knowledge of MicroRNAs and Noncoding RNAs in Virus-Infected Cells</title>
            <link>http://www.medworm.com/index.php?rid=3351365&amp;cid=s_37124_3_f&amp;fid=37124&amp;url=http%3A%2F%2Fwww.springerprotocols.com%2FAbstract%2Fdoi%2F10.1007%2F978-1-60761-588-0_3</link>
            <description>Within the past few years, microRNAs (miRNAs) and other noncoding RNAs (ncRNAs) have emerged as elements with critically high importance in posttranscriptional control of cellular and, more recently, viral processes. Endogenously produced by a component of the miRNA-guided RNA silencing machinery known as Dicer, miRNAs are known to control messenger RNA (mRNA) translation through recognition of specific binding sites usually located in their 3&amp;prime; untranslated region. Recent evidences indicate that the host miRNA pathway may represent an adapted antiviral defense mechanism that can act either by direct miRNA-mediated modulation of viral gene expression or through recognition and inactivation of structured viral RNA species by the protein components of the RNA silencing machinery such as...</description>
            <author>Springer protocols feed by Immunology</author>
            <type>news</type>
        <comments>http://www.medworm.com/rss/comments.php?id=3351365</comments>
            <pubDate>Thu, 11 Mar 2010 13:39:06 +0100</pubDate>
            <guid isPermaLink="false">3351365</guid>        </item>
        <item>
            <title>Monitoring Innate Immune Recruitment by siRNAs in Mammalian Cells</title>
            <link>http://www.medworm.com/index.php?rid=3351364&amp;cid=s_37124_3_f&amp;fid=37124&amp;url=http%3A%2F%2Fwww.springerprotocols.com%2FAbstract%2Fdoi%2F10.1007%2F978-1-60761-588-0_2</link>
            <description>The use of small interfering RNAs (siRNAs) in human therapy may be hindered by the recruitment of nonspecific effects such as the activation of innate immune responses. Recently, several innate immune receptors have been implicated in the detection of siRNAs. This chapter provides a brief overview of the current knowledge of siRNA-induced innate immunity, as well as protocols for the rapid identification of siRNAs with innate immune stimulatory activity. (Source: Springer protocols feed by Immunology)</description>
            <author>Springer protocols feed by Immunology</author>
            <type>news</type>
        <comments>http://www.medworm.com/rss/comments.php?id=3351364</comments>
            <pubDate>Thu, 11 Mar 2010 13:39:06 +0100</pubDate>
            <guid isPermaLink="false">3351364</guid>        </item>
        <item>
            <title>Endogenous Antiviral Mechanisms of RNA Interference: A Comparative Biology Perspective</title>
            <link>http://www.medworm.com/index.php?rid=3351363&amp;cid=s_37124_3_f&amp;fid=37124&amp;url=http%3A%2F%2Fwww.springerprotocols.com%2FAbstract%2Fdoi%2F10.1007%2F978-1-60761-588-0_1</link>
            <description>RNA interference (RNAi) is a natural process that occurs in many organisms ranging from plants to mammals. In this process, double-stranded RNA or hairpin RNA is cleaved by a RNaseIII-type enzyme called Dicer into small interfering RNA duplex. This then directs sequence-specific, homology-dependent, posttranscriptional gene silencing by binding to its complementary RNA and triggering its elimination through degradation or by inducing translational inhibition. In plants, worms, and insects, RNAi is a strong antiviral defense mechanism. Although, at present, it is unclear whether RNA silencing naturally restricts viral infection in vertebrates, there are signs that this is certainly the case. In a relatively short period, RNAi has progressed to become an important experimental tool both in v...</description>
            <author>Springer protocols feed by Immunology</author>
            <type>news</type>
        <comments>http://www.medworm.com/rss/comments.php?id=3351363</comments>
            <pubDate>Thu, 11 Mar 2010 13:39:05 +0100</pubDate>
            <guid isPermaLink="false">3351363</guid>        </item>
        <item>
            <title>Chemical Synthesis of 2&amp;prime;-O-Alkylated siRNAs</title>
            <link>http://www.medworm.com/index.php?rid=3351362&amp;cid=s_37124_3_f&amp;fid=37124&amp;url=http%3A%2F%2Fwww.springerprotocols.com%2FAbstract%2Fdoi%2F10.1007%2F978-1-60761-588-0_10</link>
            <description>Chemical synthesis has been a major endeavor to create active siRNAs. The downregulation of mRNA by 21-mer double-stranded siRNAs can be improved by using modified nucleotides, especially 2&amp;prime;-O-alkylated ones. Besides the commercially available 2&amp;cent;-O-methyl ribosides, 2&amp;prime;-alkyl groups bearing positive charges are especially promising candidates. We have shown that in a proper formulation they are superior to unmodified siRNAs. This may be due to enhanced stability and most probably to a better uptake into the cells. (Source: Springer protocols feed by Immunology)</description>
            <author>Springer protocols feed by Immunology</author>
            <type>news</type>
        <comments>http://www.medworm.com/rss/comments.php?id=3351362</comments>
            <pubDate>Thu, 11 Mar 2010 13:39:05 +0100</pubDate>
            <guid isPermaLink="false">3351362</guid>        </item>
        <item>
            <title>Adjuvant Activity on Murine and Human Macrophages</title>
            <link>http://www.medworm.com/index.php?rid=3284936&amp;cid=s_37124_3_f&amp;fid=37124&amp;url=http%3A%2F%2Fwww.springerprotocols.com%2FAbstract%2Fdoi%2F10.1007%2F978-1-60761-585-9_9</link>
            <description>Activation of cells of the innate immunity such as macrophages and dendritic cells is critical to mount an adaptive immune response. Recent advances on the understanding of innate immune receptors such as the Toll-like receptors (TLR) and NOD-like receptors (NLR) and the demonstration that microbial products activate specific receptors. This discovery represented a major advance and provided tools to test novel adjuvants in vitro to investigate activation on innate immune cells. Here the isolation and culture of murine macrophages is described, and the use of macrophages derived from gene-deficient mice is proposed to define receptor usage. Novel adjuvants may be tested for their capacity to induce cytokines, chemokines and the expression of costimulatory molecules. The basic methods to as...</description>
            <author>Springer protocols feed by Immunology</author>
            <type>news</type>
        <comments>http://www.medworm.com/rss/comments.php?id=3284936</comments>
            <pubDate>Fri, 19 Feb 2010 13:39:06 +0100</pubDate>
            <guid isPermaLink="false">3284936</guid>        </item>
        <item>
            <title>Adjuvant Activity on Human Cells In Vitro</title>
            <link>http://www.medworm.com/index.php?rid=3284935&amp;cid=s_37124_3_f&amp;fid=37124&amp;url=http%3A%2F%2Fwww.springerprotocols.com%2FAbstract%2Fdoi%2F10.1007%2F978-1-60761-585-9_8</link>
            <description>Efficient Vacciness against intracellular microbes or tumors will be based on innovative adjuvants able to induce efficient activation of dendritic cells. Indeed, natural or synthetic products activating Toll-like receptors (TLR) on dendritic cells (DCs) are currently in development for this purpose. Herein, we describe in vitro assays on human cells which might be useful for the preclinical screening and assessment of potential DC activators. (Source: Springer protocols feed by Immunology)</description>
            <author>Springer protocols feed by Immunology</author>
            <type>news</type>
        <comments>http://www.medworm.com/rss/comments.php?id=3284935</comments>
            <pubDate>Fri, 19 Feb 2010 13:39:06 +0100</pubDate>
            <guid isPermaLink="false">3284935</guid>        </item>
        <item>
            <title>Micro/Nanoparticle Adjuvants: Preparation and Formulation with Antigens</title>
            <link>http://www.medworm.com/index.php?rid=3284934&amp;cid=s_37124_3_f&amp;fid=37124&amp;url=http%3A%2F%2Fwww.springerprotocols.com%2FAbstract%2Fdoi%2F10.1007%2F978-1-60761-585-9_7</link>
            <description>Recombinant proteins are increasingly being used as a novel approach for antigens in Vacciness. These genetically engineered antigens are poorly immunogenic and require a delivery system and adjuvant to elicit their effect at targeted site of action. A delivery system transports the antigen to site of action and an adjuvant activates the cells via interaction with cell receptors and enhances the potency of the antigen. Micro/nanoparticles made from biodegradable and biocompatible polyesters, polylactide-co-glycolides (PLG), have been extensively used as an adjuvant and delivery system. This chapter discusses the applications of PLG micro/nanoparticles as delivery systems and adjuvant for antigens. PLG microparticles are prepared by a solvent evaporation method while nanoparticles are prepa...</description>
            <author>Springer protocols feed by Immunology</author>
            <type>news</type>
        <comments>http://www.medworm.com/rss/comments.php?id=3284934</comments>
            <pubDate>Fri, 19 Feb 2010 13:39:06 +0100</pubDate>
            <guid isPermaLink="false">3284934</guid>        </item>
        <item>
            <title>Liposomal Adjuvants: Preparation and Formulation with Antigens</title>
            <link>http://www.medworm.com/index.php?rid=3284933&amp;cid=s_37124_3_f&amp;fid=37124&amp;url=http%3A%2F%2Fwww.springerprotocols.com%2FAbstract%2Fdoi%2F10.1007%2F978-1-60761-585-9_6</link>
            <description>Many preclinical and clinical results indicate that liposomal systems can serve as effective adjuvants to subunit Vacciness by enabling the formulation and delivery of Vaccines antigens and immunopotentiators. The adjuvant effect of liposomes usually depends on both the composition of the lipid vesicles and their physical association with the Vaccines antigen. This chapter describes methods for the preparation and characterization of sterile small, mostly unilamellar, lipid vesicles and for their association with Vaccines antigens. It gives also some recommendations for the optimization of liposomal Vacciness in preclinical testing. The most common immunopotentiators used in liposomal adjuvants are also described. (Source: Springer protocols feed by Immunology)</description>
            <author>Springer protocols feed by Immunology</author>
            <type>news</type>
        <comments>http://www.medworm.com/rss/comments.php?id=3284933</comments>
            <pubDate>Fri, 19 Feb 2010 13:39:06 +0100</pubDate>
            <guid isPermaLink="false">3284933</guid>        </item>
        <item>
            <title>Freund&amp;rsquo;s Complete and Incomplete Adjuvants, Preparation, and Quality Control Standards for Experimental Laboratory Animals Use</title>
            <link>http://www.medworm.com/index.php?rid=3284932&amp;cid=s_37124_3_f&amp;fid=37124&amp;url=http%3A%2F%2Fwww.springerprotocols.com%2FAbstract%2Fdoi%2F10.1007%2F978-1-60761-585-9_5</link>
            <description>Quality control and quality assurance procedures are discussed for the agreed benchmark standard Freund&amp;rsquo;s complete adjuvant (FCA). In addition, the use of the incomplete adjuvant (FIA) in the preparation of antisera is discussed. A major problem is the use of a safe and suitable mineral oil in FCA and FIA; manufacturers should provide infra-red spectra and gas liquid chromatography analyses. A range of safety tests, toxicity, pyrogenicity and endotoxin assays and advice on practical procedures for the use of these adjuvants are described. (Source: Springer protocols feed by Immunology)</description>
            <author>Springer protocols feed by Immunology</author>
            <type>news</type>
        <comments>http://www.medworm.com/rss/comments.php?id=3284932</comments>
            <pubDate>Fri, 19 Feb 2010 13:39:06 +0100</pubDate>
            <guid isPermaLink="false">3284932</guid>        </item>
        <item>
            <title>Aluminum Adjuvants: Preparation, Application, Dosage, and Formulation with Antigen</title>
            <link>http://www.medworm.com/index.php?rid=3284931&amp;cid=s_37124_3_f&amp;fid=37124&amp;url=http%3A%2F%2Fwww.springerprotocols.com%2FAbstract%2Fdoi%2F10.1007%2F978-1-60761-585-9_4</link>
            <description>Important new knowledge about the effect of aluminum adjuvants on the immune response in terms of their impact on cytokine profiles, uptake by antigen-presenting cells (APC), and surface marker expression has been published in recent years. However, although the knowledge about these adjuvants is thus more comprehensive now than ever before, the user is often still confined to a more empirical approach when confronted with practical issues when it comes to the handling and use of these adjuvants. In this chapter we have given focus to the user&amp;rsquo;s perspective, discussing practicalities like dosage, temperature stability, relevant monographs, and preparation with antigen. (Source: Springer protocols feed by Immunology)</description>
            <author>Springer protocols feed by Immunology</author>
            <type>news</type>
        <comments>http://www.medworm.com/rss/comments.php?id=3284931</comments>
            <pubDate>Fri, 19 Feb 2010 13:39:06 +0100</pubDate>
            <guid isPermaLink="false">3284931</guid>        </item>
        <item>
            <title>Nonclinical Safety Assessment of Vacciness and Adjuvants</title>
            <link>http://www.medworm.com/index.php?rid=3284930&amp;cid=s_37124_3_f&amp;fid=37124&amp;url=http%3A%2F%2Fwww.springerprotocols.com%2FAbstract%2Fdoi%2F10.1007%2F978-1-60761-585-9_3</link>
            <description>To ensure the safe administration of Vacciness to humans, Vacciness (just like any new chemical entity) are evaluated in a series of nonclinical safety assessment studies that aim at identifying the potential toxicities associated with their administration. The nonclinical safety assessment of Vacciness, however, is only part of a testing battery performed prior to human administration, which includes (1) the evaluation of the Vaccines in efficacy and immunogenicity studies in animal models, (2) a quality control testing program, and (3) toxicology (nonclinical safety assessment) testing in relevant animal models. Although each of these evaluations plays a critical role in ensuring Vaccines safety, the nonclinical safety assessment is the most relevant to the evaluation in human clinical t...</description>
            <author>Springer protocols feed by Immunology</author>
            <type>news</type>
        <comments>http://www.medworm.com/rss/comments.php?id=3284930</comments>
            <pubDate>Fri, 19 Feb 2010 13:39:06 +0100</pubDate>
            <guid isPermaLink="false">3284930</guid>        </item>
        <item>
            <title>Preclinical Development of AS04</title>
            <link>http://www.medworm.com/index.php?rid=3284929&amp;cid=s_37124_3_f&amp;fid=37124&amp;url=http%3A%2F%2Fwww.springerprotocols.com%2FAbstract%2Fdoi%2F10.1007%2F978-1-60761-585-9_2</link>
            <description>Recent knowledge on Vaccines-induced immunity led to the development of Vaccines Adjuvant Systems specially designed and adapted to Vaccines needs. AS04 is such a tailored Adjuvant System developed by GlaxoSmithKline Biologicals. This chapter focuses on the methods that were used during the preclinical evaluation of AS04. AS04 consists of the combination of aluminum salts and 3'-O-deacylated monophosphoryl lipid A (MPL), a detoxified lipid A derivative with retained immunostimulatory capa- city. MPL also induces considerably less pro-inflammatory cytokines, as compared to the parent LPS molecule. Preclinical evaluation of AS04 allowed the determination of the optimal size of MPL particles. The added value of MPL in AS04-based formulations was evidenced by higher Vaccines-elicited antibody ...</description>
            <author>Springer protocols feed by Immunology</author>
            <type>news</type>
        <comments>http://www.medworm.com/rss/comments.php?id=3284929</comments>
            <pubDate>Fri, 19 Feb 2010 13:39:06 +0100</pubDate>
            <guid isPermaLink="false">3284929</guid>        </item>
        <item>
            <title>Immunology of Vaccines Adjuvants</title>
            <link>http://www.medworm.com/index.php?rid=3284928&amp;cid=s_37124_3_f&amp;fid=37124&amp;url=http%3A%2F%2Fwww.springerprotocols.com%2FAbstract%2Fdoi%2F10.1007%2F978-1-60761-585-9_1</link>
            <description>In recent times Vaccines adjuvants, or immunopotentiators, received abundant attention in the media as critical ingredients of current and future Vacciness. Indeed, Vaccines adjuvants are recognized to make the difference between competing Vacciness based on identical antigens. Moreover, it is recognized that Vacciness designed for certain indications require a matching combination of selected antigen(s) together with a critical immunopotentiator that selectively drives the required immune pathway with minimal adverse reactions. Recently, the mechanistic actions of some immunopotentiators have become clearer as a result of research focused on innate immunity receptors. These insights enable more rational adjuvant and Vaccines design, which, ideally, is based on predictable immunophenotypes...</description>
            <author>Springer protocols feed by Immunology</author>
            <type>news</type>
        <comments>http://www.medworm.com/rss/comments.php?id=3284928</comments>
            <pubDate>Fri, 19 Feb 2010 13:39:06 +0100</pubDate>
            <guid isPermaLink="false">3284928</guid>        </item>
        <item>
            <title>Adjuvant Activity of Cytokines</title>
            <link>http://www.medworm.com/index.php?rid=3284927&amp;cid=s_37124_3_f&amp;fid=37124&amp;url=http%3A%2F%2Fwww.springerprotocols.com%2FAbstract%2Fdoi%2F10.1007%2F978-1-60761-585-9_19</link>
            <description>The activity of several potent adjuvants, including incomplete Freund&amp;rsquo;s adjuvant, CpG oligodeoxynucleotides, and alum, has been shown to be due at least in part to the induction of cytokines, including type I interferons (IFNs), IFN-?, interleukin-2 (IL-2), and IL-12, that play key roles in the regulation of innate and adaptive immunity. The relatively short half-life of recombinant homologues of cytokines has limited their use as Vaccines adjuvants. These difficulties have been overcome by encapsulation into liposomes and the use of cytokine expression vectors co-administered with DNA Vacciness. Although a number of cytokines including IFN-a, IFN-?, IL-2, IL-12, IL-15, IL-18, IL-21, GM-CSF, and Flt-3 ligand have been shown to potentiate the immune response to vaccination in various ...</description>
            <author>Springer protocols feed by Immunology</author>
            <type>news</type>
        <comments>http://www.medworm.com/rss/comments.php?id=3284927</comments>
            <pubDate>Fri, 19 Feb 2010 13:39:06 +0100</pubDate>
            <guid isPermaLink="false">3284927</guid>        </item>
        <item>
            <title>Determining the Activity of Mucosal Adjuvants</title>
            <link>http://www.medworm.com/index.php?rid=3284926&amp;cid=s_37124_3_f&amp;fid=37124&amp;url=http%3A%2F%2Fwww.springerprotocols.com%2FAbstract%2Fdoi%2F10.1007%2F978-1-60761-585-9_18</link>
            <description>Mucosal vaccination offers the advantage of blocking pathogens at the portal of entry, improving patient&amp;rsquo;s compliance, facilitating Vaccines delivery, and decreasing the risk of unwanted spread of infectious agents via contaminated syringes. (Source: Springer protocols feed by Immunology)</description>
            <author>Springer protocols feed by Immunology</author>
            <type>news</type>
        <comments>http://www.medworm.com/rss/comments.php?id=3284926</comments>
            <pubDate>Fri, 19 Feb 2010 13:39:06 +0100</pubDate>
            <guid isPermaLink="false">3284926</guid>        </item>
        <item>
            <title>Large-Animal Model for Establishing E/T Ratio of Adjuvants</title>
            <link>http://www.medworm.com/index.php?rid=3284925&amp;cid=s_37124_3_f&amp;fid=37124&amp;url=http%3A%2F%2Fwww.springerprotocols.com%2FAbstract%2Fdoi%2F10.1007%2F978-1-60761-585-9_17</link>
            <description>To develop novel adjuvants for use in humans, the efficacy/toxicity (E/T) ratio of experimental products in large animal species can be investigated. The test model included two intramuscular immunizations in pigs at 3 weeks interval and analysis of immune responses and local reactions 1 week after the second injection. The antigen used to determine adjuvant activity was a well-defined, purified, viral glycoprotein that without adjuvant induces low immune responses and no detectable local reactions. Efficacy was determined by measuring ELISA and virus-neutralizing antibody titres. Toxicity was determined by necropsy and estimating size and severity of local reactions to each treatment. The persistence of the side effects was deduced from the difference in the local reaction 4 weeks after t...</description>
            <author>Springer protocols feed by Immunology</author>
            <type>news</type>
        <comments>http://www.medworm.com/rss/comments.php?id=3284925</comments>
            <pubDate>Fri, 19 Feb 2010 13:39:05 +0100</pubDate>
            <guid isPermaLink="false">3284925</guid>        </item>
        <item>
            <title>Quantitative Multiparameter Assays to Measure the Effect of Adjuvants on Human Antigen-Specific CD8 T-Cell Responses</title>
            <link>http://www.medworm.com/index.php?rid=3284924&amp;cid=s_37124_3_f&amp;fid=37124&amp;url=http%3A%2F%2Fwww.springerprotocols.com%2FAbstract%2Fdoi%2F10.1007%2F978-1-60761-585-9_16</link>
            <description>Large numbers and functionally competent T cells are required to protect from diseases for which antibody-based Vacciness have consistently failed (1), which is the case for many chronic viral infections and solid tumors. Therefore, therapeutic Vacciness aim at the induction of strong antigen-specific T-cell responses. Novel adjuvants have considerably improved the capacity of synthetic Vacciness to activate T cells, but more research is necessary to identify optimal compositions of potent Vaccines formulations. Consequently, there is a great need to develop accurate methods for the efficient identification of antigen-specific T cells and the assessment of their functional characteristics directly ex vivo. In this regard, hundreds of clinical vaccination trials have been implemented during...</description>
            <author>Springer protocols feed by Immunology</author>
            <type>news</type>
        <comments>http://www.medworm.com/rss/comments.php?id=3284924</comments>
            <pubDate>Fri, 19 Feb 2010 13:39:05 +0100</pubDate>
            <guid isPermaLink="false">3284924</guid>        </item>
        <item>
            <title>Determining Adjuvant Activity on T-Cell Function In Vivo: Th Cells</title>
            <link>http://www.medworm.com/index.php?rid=3284923&amp;cid=s_37124_3_f&amp;fid=37124&amp;url=http%3A%2F%2Fwww.springerprotocols.com%2FAbstract%2Fdoi%2F10.1007%2F978-1-60761-585-9_15</link>
            <description>Adjuvants constitute a critical component in Vaccines development in terms of both stimulating and directing immune responses of a suitable profile to promote protection against a diverse range of disease targets. In the past, the field of adjuvant research was mainly dominated by empirical testing and serendipity. However, there is a strong need to develop new generations of adjuvants based on rational design, as well as a requirement to characterise and comprehend their mechanism(s) of action. Adjuvant development can be characterised as an iterative process where potential candidates are repeatedly tested in vitro and in vivo for immunogenicity and optimised in terms of formulation and delivery. Novel lead candidates of adjuvants with a suitable immunological profile relative to specifi...</description>
            <author>Springer protocols feed by Immunology</author>
            <type>news</type>
        <comments>http://www.medworm.com/rss/comments.php?id=3284923</comments>
            <pubDate>Fri, 19 Feb 2010 13:39:05 +0100</pubDate>
            <guid isPermaLink="false">3284923</guid>        </item>
        <item>
            <title>Functional Antibody Assays</title>
            <link>http://www.medworm.com/index.php?rid=3284922&amp;cid=s_37124_3_f&amp;fid=37124&amp;url=http%3A%2F%2Fwww.springerprotocols.com%2FAbstract%2Fdoi%2F10.1007%2F978-1-60761-585-9_14</link>
            <description>Functional antibody assays can broadly be divided into three categories: neutralisation, serum bactericidal antibody (SBA) and opsonophagocytic assays (OPA). These biological assays are generally more complex than antibody-binding counterparts. They invariably involve multiple biological components, many of which are difficult or impossible to standardise. The aim of this chapter is to provide working examples of these assays and highlight the key issues to be addressed to ensure they are able to provide reliable data. (Source: Springer protocols feed by Immunology)</description>
            <author>Springer protocols feed by Immunology</author>
            <type>news</type>
        <comments>http://www.medworm.com/rss/comments.php?id=3284922</comments>
            <pubDate>Fri, 19 Feb 2010 13:39:05 +0100</pubDate>
            <guid isPermaLink="false">3284922</guid>        </item>
        <item>
            <title>Adjuvant Effects on Antibody Titre</title>
            <link>http://www.medworm.com/index.php?rid=3284921&amp;cid=s_37124_3_f&amp;fid=37124&amp;url=http%3A%2F%2Fwww.springerprotocols.com%2FAbstract%2Fdoi%2F10.1007%2F978-1-60761-585-9_13</link>
            <description>Antibody titre is a measure of the presence and amount of antibodies specific to an antigen that are present in the blood. In particular, the titre of an antibody sample is a measure of the antibody concentration determined under a defined set of conditions, with the antibody concentration being commonly established by enzyme-linked immunosorbent assay, also called ELISA, or a variation of this technology. (Source: Springer protocols feed by Immunology)</description>
            <author>Springer protocols feed by Immunology</author>
            <type>news</type>
        <comments>http://www.medworm.com/rss/comments.php?id=3284921</comments>
            <pubDate>Fri, 19 Feb 2010 13:39:05 +0100</pubDate>
            <guid isPermaLink="false">3284921</guid>        </item>
        <item>
            <title>Tracking Dendritic Cells In Vivo</title>
            <link>http://www.medworm.com/index.php?rid=3284920&amp;cid=s_37124_3_f&amp;fid=37124&amp;url=http%3A%2F%2Fwww.springerprotocols.com%2FAbstract%2Fdoi%2F10.1007%2F978-1-60761-585-9_12</link>
            <description>The reasons why certain Vaccines adjuvants and/or delivery systems are more or less effective at inducing immune responses or promoting the preferential induction of particular types of response are unknown. While Vaccines antigen discovery has benefited from a systematic approach, our limited understanding of the interactions of adjuvants with cells of the immune system has hampered rational adjuvant discovery and handicapped the development of new and more effective Vacciness. It is well accepted that the component parts of the immune system do not work in isolation and their interactions occur in distinct and specialised micro- and macro-anatomical locations. Consequently, significant obstacles to the systematic investigation of adjuvant effects have been the complexity of the physiolog...</description>
            <author>Springer protocols feed by Immunology</author>
            <type>news</type>
        <comments>http://www.medworm.com/rss/comments.php?id=3284920</comments>
            <pubDate>Fri, 19 Feb 2010 13:39:05 +0100</pubDate>
            <guid isPermaLink="false">3284920</guid>        </item>
        <item>
            <title>NKT Cell Responses to Glycolipid Activation</title>
            <link>http://www.medworm.com/index.php?rid=3284919&amp;cid=s_37124_3_f&amp;fid=37124&amp;url=http%3A%2F%2Fwww.springerprotocols.com%2FAbstract%2Fdoi%2F10.1007%2F978-1-60761-585-9_11</link>
            <description>NKT cells are a distinct lineage of T lymphocytes that are usually identified by the co-expression of the semi-invariant CD1d-restricted a&amp;szlig; TCR and the NK1.1 allelic marker of NK lineage receptors in the C57BL/6 mice and related strains. NKT cells can be subdivided based on CD4/CD8 expression and on tissue of origin. NKT cells express significantly the TCR gene products Va24&amp;nbsp;JaQ in humans, the homolog of mouse Va14&amp;nbsp;Ja18, paired with V&amp;szlig;11, the homolog of mouse V&amp;szlig;8.2. NKT cells are most frequent in liver (up to 30% of T cells in mice and approximately 4% of hepatic T cells in human), bone marrow, and thymus and represent a smaller proportion of T cells in other tissues including spleen, lymph nodes, blood, and lung. NKT cells recognize a broad array of glycolipids...</description>
            <author>Springer protocols feed by Immunology</author>
            <type>news</type>
        <comments>http://www.medworm.com/rss/comments.php?id=3284919</comments>
            <pubDate>Fri, 19 Feb 2010 13:39:05 +0100</pubDate>
            <guid isPermaLink="false">3284919</guid>        </item>
        <item>
            <title>In Vitro Effects of Adjuvants on B Cells</title>
            <link>http://www.medworm.com/index.php?rid=3284918&amp;cid=s_37124_3_f&amp;fid=37124&amp;url=http%3A%2F%2Fwww.springerprotocols.com%2FAbstract%2Fdoi%2F10.1007%2F978-1-60761-585-9_10</link>
            <description>Stimulation of B cells not only through the B cell antigen receptor (BCR) but also through Toll-like receptors (TLRs) can drive activation, proliferation, and differentiation of B cells to result in antigen-specific antibody secretion. In addition, B cells are co-stimulated by specific antigen and the presence of a TLR ligand such as for TLR9, which selectively enhances the development of antigen-specific antibodies and endows B cells with strong antigen-presenting capabilities to T cells. These effects promote antigen-specific immune responses and account for the strong adjuvant effect of TLR9 ligands. Several studies have described the activation of human or murine B cells by TLR ligands or other adjuvants. However, there are no reports summarizing the various different effects adjuvants...</description>
            <author>Springer protocols feed by Immunology</author>
            <type>news</type>
        <comments>http://www.medworm.com/rss/comments.php?id=3284918</comments>
            <pubDate>Fri, 19 Feb 2010 13:39:04 +0100</pubDate>
            <guid isPermaLink="false">3284918</guid>        </item>
        <item>
            <title>Characterization of the Leishmanicidal Activity of Antimicrobial Peptides</title>
            <link>http://www.medworm.com/index.php?rid=3213507&amp;cid=s_37124_3_f&amp;fid=37124&amp;url=http%3A%2F%2Fwww.springerprotocols.com%2FAbstract%2Fdoi%2F10.1007%2F978-1-60761-594-1_25</link>
            <description>This chapter describes the basic methodology to assay the activity of antimicrobial peptides (AMPs) on Leishmania, a human protozoan parasite. The protocols included can be methodologically divided into two major blocks. The first one addresses the basic technology for growth of the different stages of Leishmania, assessment of leishmanicidal activity, and monitoring of plasma membrane permeabilization. The second block encompasses the monitoring of bioenergetic parameters of the parasite, visualization of structural damage by transmission electron microscopy, or those methods more closely related to the involvement of intracellular AMP targets, as subcellular localization of the peptide and induction of parasite apoptosis. (Source: Springer protocols feed by Immunology)</description>
            <author>Springer protocols feed by Immunology</author>
            <type>news</type>
        <comments>http://www.medworm.com/rss/comments.php?id=3213507</comments>
            <pubDate>Fri, 22 Jan 2010 00:00:00 +0100</pubDate>
            <guid isPermaLink="false">3213507</guid>        </item>
        <item>
            <title>Antimicrobial and Antibiofilm Activity of Quorum Sensing Peptides and Peptide Analogues Against Oral Biofilm Bacteria</title>
            <link>http://www.medworm.com/index.php?rid=3213506&amp;cid=s_37124_3_f&amp;fid=37124&amp;url=http%3A%2F%2Fwww.springerprotocols.com%2FAbstract%2Fdoi%2F10.1007%2F978-1-60761-594-1_24</link>
            <description>Widespread antibiotic resistance is a major incentive for the investigation of novel ways to treat or prevent infections. Much effort has been put into the discovery of peptides in nature accompanied by manipulation of natural peptides to improve activity and decrease toxicity. The ever increasing knowledge about bacteria and the discovery of quorum sensing have presented itself as another mechanism to disrupt the infection process. We have shown that the natural quorum sensing (QS) peptide, competence-stimulating peptide (CSP), used by the caries causing bacteria Streptococcus mutans when used in higher than normally present concentrations can actually contribute to cell death in S. mutans. Using an analogue of this quorum sensing peptide (KBI-3221), we have shown it to be beneficial at d...</description>
            <author>Springer protocols feed by Immunology</author>
            <type>news</type>
        <comments>http://www.medworm.com/rss/comments.php?id=3213506</comments>
            <pubDate>Fri, 22 Jan 2010 00:00:00 +0100</pubDate>
            <guid isPermaLink="false">3213506</guid>        </item>
        <item>
            <title>Measuring Antimicrobial Peptide Activity on Epithelial Surfaces in Cell Culture</title>
            <link>http://www.medworm.com/index.php?rid=3213505&amp;cid=s_37124_3_f&amp;fid=37124&amp;url=http%3A%2F%2Fwww.springerprotocols.com%2FAbstract%2Fdoi%2F10.1007%2F978-1-60761-594-1_23</link>
            <description>To more accurately assess the activity and role of epithelial cell-derived antimicrobial peptides in their native settings, it is essential to perform assays at the surfaces under relevant conditions. In order to carry this out, we utilize three-dimensional cultures of airway and gingival epithelium, which are grown at an air&amp;ndash;liquid interface. Under these conditions, the cultures can be subjected to challenge with a variety of factors known to cause an increase in antimicrobial peptide gene expression. The functional relevance of this induction can then be assessed by quantifying antibacterial activity either directly on the surface of the cells or using the fluid secreted onto the apical surface of the cultures. The relative contribution of the peptides can also be measured by pre-i...</description>
            <author>Springer protocols feed by Immunology</author>
            <type>news</type>
        <comments>http://www.medworm.com/rss/comments.php?id=3213505</comments>
            <pubDate>Fri, 22 Jan 2010 00:00:00 +0100</pubDate>
            <guid isPermaLink="false">3213505</guid>        </item>
        <item>
            <title>Ex Vivo Skin Infection Model</title>
            <link>http://www.medworm.com/index.php?rid=3213504&amp;cid=s_37124_3_f&amp;fid=37124&amp;url=http%3A%2F%2Fwww.springerprotocols.com%2FAbstract%2Fdoi%2F10.1007%2F978-1-60761-594-1_22</link>
            <description>Over the past decade, the emergence of bacterial strains resistant to conventional antibiotics has necessitated the discovery and development of new antimicrobial therapies. This chapter describes a skin infection model that is based on the use of excised skin derived from the domestic pig. The model conditions mimic the environment of human skin and efficiently support the growth of clinically relevant bacterial and fungal species, thus making it useful for evaluating the activity of antimicrobial peptides and other antibiotics as well as their respective formulations. (Source: Springer protocols feed by Immunology)</description>
            <author>Springer protocols feed by Immunology</author>
            <type>news</type>
        <comments>http://www.medworm.com/rss/comments.php?id=3213504</comments>
            <pubDate>Fri, 22 Jan 2010 00:00:00 +0100</pubDate>
            <guid isPermaLink="false">3213504</guid>        </item>
        <item>
            <title>Assay Systems for Measurement of Anti-inflammatory Activity</title>
            <link>http://www.medworm.com/index.php?rid=3213503&amp;cid=s_37124_3_f&amp;fid=37124&amp;url=http%3A%2F%2Fwww.springerprotocols.com%2FAbstract%2Fdoi%2F10.1007%2F978-1-60761-594-1_21</link>
            <description>It is widely accepted that cationic antimicrobial peptides possess potent microbicidal properties. Recent studies show that in addition to their antimicrobial action, these peptides can exhibit anti-inflammatory activity. The purpose of this chapter is to describe in vivo ear inflammation models that can be used for evaluating the anti-inflammatory activity of antimicrobial peptides. The models are based on different mechanisms of inflammation development and include irritant dermatitis (a model induced by a single application of 12-o-tetradecanoylphorbol acetate [TPA]) and allergic dermatitis, or delayed type hypersensitivity reaction (a model induced by repetitive application of oxazolone). (Source: Springer protocols feed by Immunology)</description>
            <author>Springer protocols feed by Immunology</author>
            <type>news</type>
        <comments>http://www.medworm.com/rss/comments.php?id=3213503</comments>
            <pubDate>Fri, 22 Jan 2010 00:00:00 +0100</pubDate>
            <guid isPermaLink="false">3213503</guid>        </item>
        <item>
            <title>Therapeutic Potential of HDPs as Immunomodulatory Agents</title>
            <link>http://www.medworm.com/index.php?rid=3213502&amp;cid=s_37124_3_f&amp;fid=37124&amp;url=http%3A%2F%2Fwww.springerprotocols.com%2FAbstract%2Fdoi%2F10.1007%2F978-1-60761-594-1_20</link>
            <description>One of the most significant advances in medical history is the discovery and development of antibiotics, which in the middle of last century was flourishing and appeared to be the ultimate solution to the treatment of life-threatening human bacterial diseases. However, lately there has been a huge decline in the rate of discovery of new antimicrobial intervention strategies in parallel with an increasing incidence of multidrug-resistant pathogens; if these circumstances do not change we will continue to approach the end of the antibiotic era. Facing this dark future, scientists are considering new strategies for intervention tailored around the appropriate (selective) stimulation of the host&amp;rsquo;s immune system, and particularly rapid acting innate immunity, as an alternative to direct t...</description>
            <author>Springer protocols feed by Immunology</author>
            <type>news</type>
        <comments>http://www.medworm.com/rss/comments.php?id=3213502</comments>
            <pubDate>Fri, 22 Jan 2010 00:00:00 +0100</pubDate>
            <guid isPermaLink="false">3213502</guid>        </item>
        <item>
            <title>Potential Therapeutic Application of Host Defense Peptides</title>
            <link>http://www.medworm.com/index.php?rid=3213501&amp;cid=s_37124_3_f&amp;fid=37124&amp;url=http%3A%2F%2Fwww.springerprotocols.com%2FAbstract%2Fdoi%2F10.1007%2F978-1-60761-594-1_19</link>
            <description>Host defense peptides (HDPs) are relatively small, mostly cationic, amphipathic, and of variable length, sequence, and structure. The majority of these peptides exhibit broad-spectrum antimicrobial activity and often activity against viruses and some cancer cell lines. In addition, HDPs also provide a range of immunomodulatory activities related to innate immunity defense, inflammation, and wound healing. The development of these multi-faceted molecules and their bioactivities into clinically important therapeutics is being pursued using a number of different approaches. Here we review the role of HDPs in nature and application of this role to the development of novel therapeutics. (Source: Springer protocols feed by Immunology)</description>
            <author>Springer protocols feed by Immunology</author>
            <type>news</type>
        <comments>http://www.medworm.com/rss/comments.php?id=3213501</comments>
            <pubDate>Fri, 22 Jan 2010 00:00:00 +0100</pubDate>
            <guid isPermaLink="false">3213501</guid>        </item>
        <item>
            <title>Computer-Based Analysis, Visualization, and Interpretation of Antimicrobial Peptide Activities</title>
            <link>http://www.medworm.com/index.php?rid=3213500&amp;cid=s_37124_3_f&amp;fid=37124&amp;url=http%3A%2F%2Fwww.springerprotocols.com%2FAbstract%2Fdoi%2F10.1007%2F978-1-60761-594-1_18</link>
            <description>This chapter describes a computer-based method for analyzing the quantitative structure&amp;ndash;activity relationships (QSAR) of antimicrobial peptides. Quantitative or qualitative activity measurements and known peptide sequences are used as input for the analysis. The analysis steps consist of the preprocessing which specifically deals with dilution series from an assay with luminescent bacteria, transformation of quantitative activity values into activity classes, a feature extraction method using molecular descriptors for amino acids, feature selection methods, visualization strategies, the classifier model design for discrimination of active and inactive peptides, and the in silico design of promising new peptide candidates. (Source: Springer protocols feed by Immunology)</description>
            <author>Springer protocols feed by Immunology</author>
            <type>news</type>
        <comments>http://www.medworm.com/rss/comments.php?id=3213500</comments>
            <pubDate>Fri, 22 Jan 2010 00:00:00 +0100</pubDate>
            <guid isPermaLink="false">3213500</guid>        </item>
        <item>
            <title>Molecular Simulations of Antimicrobial Peptides</title>
            <link>http://www.medworm.com/index.php?rid=3213499&amp;cid=s_37124_3_f&amp;fid=37124&amp;url=http%3A%2F%2Fwww.springerprotocols.com%2FAbstract%2Fdoi%2F10.1007%2F978-1-60761-594-1_17</link>
            <description>Recent advances in molecular dynamics (MD) simulation methods and in available computational resources have allowed for more reliable simulations of biological phenomena. From all-atom MD simulations, we are now able to visualize in detail the interactions between antimicrobial peptides (AMPs) and a variety of membrane mimics. This helps us to understand the molecular mechanisms of antimicrobial activity and toxicity. This chapter describes how to set up and conduct molecular dynamics simulations of AMPs and membrane mimics. Details are given for the construction of systems of interest for studying AMPs, which can include simulations of peptides in water, micelles, or lipid bilayers. Explanations of the parameters needed for running a simulation are provided as well. (Source: Springer prot...</description>
            <author>Springer protocols feed by Immunology</author>
            <type>news</type>
        <comments>http://www.medworm.com/rss/comments.php?id=3213499</comments>
            <pubDate>Fri, 22 Jan 2010 00:00:00 +0100</pubDate>
            <guid isPermaLink="false">3213499</guid>        </item>
        <item>
            <title>Fluorescence and Electron Microscopy Methods for Exploring Antimicrobial Peptides Mode(s) of Action</title>
            <link>http://www.medworm.com/index.php?rid=3213498&amp;cid=s_37124_3_f&amp;fid=37124&amp;url=http%3A%2F%2Fwww.springerprotocols.com%2FAbstract%2Fdoi%2F10.1007%2F978-1-60761-594-1_16</link>
            <description>Due to the increasing resistance of microbial pathogens to the available drugs, the identification of new antimicrobial agents with a new mechanism of action is urgently needed. In this context, cationic antimicrobial peptides (AMPs) are considered promising candidates. Although there is evidence that, in contrast to conventional antibiotics, microbial membranes are the principal target of a large number of AMPs, thus making it difficult for the pathogen to acquire resistance, their mode(s) of action is not yet completely clear. Intense research is currently devoted to understand the effect(s) of AMPs on intact cells, either at sub-lethal or at lethal peptide concentrations, and fluorescence/electron microscopy techniques represent a valid tool to get insight into the damage caused by thes...</description>
            <author>Springer protocols feed by Immunology</author>
            <type>news</type>
        <comments>http://www.medworm.com/rss/comments.php?id=3213498</comments>
            <pubDate>Fri, 22 Jan 2010 00:00:00 +0100</pubDate>
            <guid isPermaLink="false">3213498</guid>        </item>
        <item>
            <title>Use of Atomic Force Microscopy as a Tool to Understand the Action of Antimicrobial Peptides on Bacteria</title>
            <link>http://www.medworm.com/index.php?rid=3213497&amp;cid=s_37124_3_f&amp;fid=37124&amp;url=http%3A%2F%2Fwww.springerprotocols.com%2FAbstract%2Fdoi%2F10.1007%2F978-1-60761-594-1_15</link>
            <description>Atomic force microscopy (AFM) has been extensively used to image the three-dimensional surface morphology of a broad range of biological samples, including Gram-negative bacteria, imaged in the presence of antimicrobial peptides (AMPs). Although this technique provides high molecular resolution, it only requires minimum sample treatment and can even be performed in liquid and at varying temperatures while keeping the bacterial cells viable. In this chapter, we describe an easy, fast, and yet effective method for preparing AMP-treated Gram-negative bacteria samples for AFM imaging. The results obtained using this method show a series of morphological changes of Gram-negative bacteria upon treatment with selected AMPs, thus providing vivid insights into the mechanisms of how AMPs perturb and...</description>
            <author>Springer protocols feed by Immunology</author>
            <type>news</type>
        <comments>http://www.medworm.com/rss/comments.php?id=3213497</comments>
            <pubDate>Fri, 22 Jan 2010 00:00:00 +0100</pubDate>
            <guid isPermaLink="false">3213497</guid>        </item>
        <item>
            <title>Solid-State NMR Investigations of Membrane-Associated Antimicrobial Peptides</title>
            <link>http://www.medworm.com/index.php?rid=3213496&amp;cid=s_37124_3_f&amp;fid=37124&amp;url=http%3A%2F%2Fwww.springerprotocols.com%2FAbstract%2Fdoi%2F10.1007%2F978-1-60761-594-1_14</link>
            <description>Solid-state NMR and other biophysical investigations have revealed many mechanistic details about the interactions of antimicrobial peptides with membranes. These studies have shaped our view on how these peptides cause the killing of bacteria, fungi, or tumour cells and how they permeabilize model membranes. As a result, we better understand the biological activities of these peptides and we are now able to design new and better sequences. Here we present some of the tools that have allowed these solid-state NMR investigations, including detailed protocols on how to reconstitute the peptides into oriented or non-oriented membranes as well as simple set-up procedures for 2H as well as proton-decoupled 31P or 15N solid-state NMR measurements. Static and magic angle spinning experiments are ...</description>
            <author>Springer protocols feed by Immunology</author>
            <type>news</type>
        <comments>http://www.medworm.com/rss/comments.php?id=3213496</comments>
            <pubDate>Fri, 22 Jan 2010 00:00:00 +0100</pubDate>
            <guid isPermaLink="false">3213496</guid>        </item>
        <item>
            <title>Dynamic Transitions of Membrane-Active Peptides</title>
            <link>http://www.medworm.com/index.php?rid=3213495&amp;cid=s_37124_3_f&amp;fid=37124&amp;url=http%3A%2F%2Fwww.springerprotocols.com%2FAbstract%2Fdoi%2F10.1007%2F978-1-60761-594-1_13</link>
            <description>Membrane-active peptides or protein segments play an important role in many biological processes at the cellular interface to the environment. They are involved, e.g., in cellular fusion or host defense, where they can cause not only merging but also the destabilization of cell membranes. Many factors determine how these typically amphipathic peptides interact with the lipid bilayer. For example, the peptide orientation in the membrane determines which parts of the peptide are exposed to the hydrophobic bilayer interior or to the polar lipid/water interface. As another example, oligomerization is required for many activities such as pore formation. Peptides have been often classified according to a single characteristic mode of interaction with the bilayer, but over the years a more versat...</description>
            <author>Springer protocols feed by Immunology</author>
            <type>news</type>
        <comments>http://www.medworm.com/rss/comments.php?id=3213495</comments>
            <pubDate>Fri, 22 Jan 2010 00:00:00 +0100</pubDate>
            <guid isPermaLink="false">3213495</guid>        </item>
        <item>
            <title>Comparing Bacterial Membrane Interactions of Antimicrobial Peptides and Their Mimics</title>
            <link>http://www.medworm.com/index.php?rid=3213494&amp;cid=s_37124_3_f&amp;fid=37124&amp;url=http%3A%2F%2Fwww.springerprotocols.com%2FAbstract%2Fdoi%2F10.1007%2F978-1-60761-594-1_12</link>
            <description>Interactions with bacterial membranes are integral to the mechanisms of action of all antimicrobial peptides (AMPs), regardless of their final cellular targets. Here, we describe in detail two biophysical techniques that can be used to measure the membrane activities of AMPs and antimicrobial peptidomimetics: (1) a calcein leakage assay to investigate interactions between AMPs/peptidomimetics with large unilamellar vesicles and (2) a potential-sensitive dye-based depolarization assay to investigate interactions with the membranes of live bacteria. By comparing the membrane interactions of AMPs and their mimics, these techniques can provide insights into their extent of mimicry and their antimicrobial mechanisms. (Source: Springer protocols feed by Immunology)</description>
            <author>Springer protocols feed by Immunology</author>
            <type>news</type>
        <comments>http://www.medworm.com/rss/comments.php?id=3213494</comments>
            <pubDate>Fri, 22 Jan 2010 00:00:00 +0100</pubDate>
            <guid isPermaLink="false">3213494</guid>        </item>
        <item>
            <title>Binding and Permeabilization of Model Membranes by Amphipathic Peptides</title>
            <link>http://www.medworm.com/index.php?rid=3213493&amp;cid=s_37124_3_f&amp;fid=37124&amp;url=http%3A%2F%2Fwww.springerprotocols.com%2FAbstract%2Fdoi%2F10.1007%2F978-1-60761-594-1_11</link>
            <description>Measurement of binding and activity of antimicrobial and cytolytic amphipathic peptides on membranes is essential to understanding their function and cell specificity. The use of model systems has provided a wealth of information on the interactions of amphipathic peptides with membranes. Binding of peptides to membranes can be monitored by measuring F&amp;ouml;rster resonance energy transfer from a Trp residue on the peptide to a lipid fluorophore incorporated in the membrane. Especially for peptides that perturb or disrupt the membrane, it is advantageous to perform these measurements as a function of time, rather than in steady state. The activity of these amphipathic peptides toward model membranes is usually measured by dye efflux kinetics. One of those methods, based on self-quenching of...</description>
            <author>Springer protocols feed by Immunology</author>
            <type>news</type>
        <comments>http://www.medworm.com/rss/comments.php?id=3213493</comments>
            <pubDate>Fri, 22 Jan 2010 00:00:00 +0100</pubDate>
            <guid isPermaLink="false">3213493</guid>        </item>
        <item>
            <title>Antimicrobial Peptides: The LPS Connection</title>
            <link>http://www.medworm.com/index.php?rid=3213492&amp;cid=s_37124_3_f&amp;fid=37124&amp;url=http%3A%2F%2Fwww.springerprotocols.com%2FAbstract%2Fdoi%2F10.1007%2F978-1-60761-594-1_10</link>
            <description>An expanding body of evidence is rendering manifest that many cationic antimicrobial peptides are endowed with different properties and activities, well beyond their direct action on microbes. One of the most interesting and potentially important research avenue on the alternative use of antimicrobial peptides grounds on their affinity toward lipopolysaccharide (LPS), the endotoxin, responsible for the systemic inflammatory response syndrome (SIRS) and related, often fatal, disorders that can follow Gram-negative infections. Indeed, not only do several antimicrobial peptides, such as cathelicidins, display an ability to strongly bind LPS and break its aggregates, but they have also been demonstrated to suppress LPS-induced pro-inflammatory responses in vitro and to protect from sepsis in a...</description>
            <author>Springer protocols feed by Immunology</author>
            <type>news</type>
        <comments>http://www.medworm.com/rss/comments.php?id=3213492</comments>
            <pubDate>Fri, 22 Jan 2010 00:00:00 +0100</pubDate>
            <guid isPermaLink="false">3213492</guid>        </item>
        <item>
            <title>High-Throughput Screening for Antimicrobial Peptides Using the SPOT Technique</title>
            <link>http://www.medworm.com/index.php?rid=3213491&amp;cid=s_37124_3_f&amp;fid=37124&amp;url=http%3A%2F%2Fwww.springerprotocols.com%2FAbstract%2Fdoi%2F10.1007%2F978-1-60761-594-1_9</link>
            <description>The SPOT technique provides a fast, cost-efficient, and highly parallel method to synthesize peptide arrays on cellulose. Peptides synthesized on cellulose can be easily cleaved from the support and used directly in a screening assay for antimicrobial activity. Depending on the equipment, the synthesis and the screening can be performed in a medium- or high-throughput manner. High-sensitivity screening is achieved using a bacterial strain (e.g., Pseudomonas aeruginosa H1001) in which a luminescence-encoding gene cassette has been introduced. The intensity of light produced is directly dependent on the energy level of the bacteria. This screening supports the development of new drugs against multidrug-resistant bacteria. (Source: Springer protocols feed by Immunology)</description>
            <author>Springer protocols feed by Immunology</author>
            <type>news</type>
        <comments>http://www.medworm.com/rss/comments.php?id=3213491</comments>
            <pubDate>Fri, 22 Jan 2010 00:00:00 +0100</pubDate>
            <guid isPermaLink="false">3213491</guid>        </item>
        <item>
            <title>Synthesis of Antimicrobial Peptides Using the SPOT Technique</title>
            <link>http://www.medworm.com/index.php?rid=3213490&amp;cid=s_37124_3_f&amp;fid=37124&amp;url=http%3A%2F%2Fwww.springerprotocols.com%2FAbstract%2Fdoi%2F10.1007%2F978-1-60761-594-1_8</link>
            <description>Developing new lead structures for drugs against multiresistant bacteria is an urgent need for modern medicine. Antimicrobial peptides are a class of drugs that can be used to discover such structures. In order to support development of this research, a fast, easy, and inexpensive method to synthesize peptides is necessary. The SPOT synthesis has the potential to produce the required peptide arrays, synthesizing up to 8,000 peptides, peptide mixtures, or other organic compounds on cellulose or other planar surfaces in a positionally addressable and multiple manner. Protocols for the preparation of cellulose membranes and the SPOT synthesis as well as cleavage of peptides from the support are described. (Source: Springer protocols feed by Immunology)</description>
            <author>Springer protocols feed by Immunology</author>
            <type>news</type>
        <comments>http://www.medworm.com/rss/comments.php?id=3213490</comments>
            <pubDate>Fri, 22 Jan 2010 00:00:00 +0100</pubDate>
            <guid isPermaLink="false">3213490</guid>        </item>
        <item>
            <title>Synthesis and Thermodynamic Characterization of Small Cyclic Antimicrobial Arginine and Tryptophan-Rich Peptides with Selectivity for Gram-Negative Bacteria</title>
            <link>http://www.medworm.com/index.php?rid=3213489&amp;cid=s_37124_3_f&amp;fid=37124&amp;url=http%3A%2F%2Fwww.springerprotocols.com%2FAbstract%2Fdoi%2F10.1007%2F978-1-60761-594-1_7</link>
            <description>One promising strategy to combat the proliferation of bacteria resistance toward current antibiotics is the development of peptide-based drug. Among these compounds is a group of small cyclic peptides rich in arginine (Arg) and tryptophan (Trp) residues with selective toxicity toward Gram-negative bacteria. The small size of these peptides with improved toxicity toward Gram-negative bacteria makes them an interesting candidate to understand the forces responsible for their selectivity and paves the way to develop new therapeutics with potent activity toward multi-resistant Gram-negative bacteria. To reach this goal, isothermal titration calorimetry (ITC) is a useful technique which may provide the complete set of thermodynamic parameters of the interaction of peptides with lipid bilayers m...</description>
            <author>Springer protocols feed by Immunology</author>
            <type>news</type>
        <comments>http://www.medworm.com/rss/comments.php?id=3213489</comments>
            <pubDate>Fri, 22 Jan 2010 00:00:00 +0100</pubDate>
            <guid isPermaLink="false">3213489</guid>        </item>
        <item>
            <title>Methods for Building Quantitative Structure&amp;ndash;Activity Relationship (QSAR) Descriptors and Predictive Models for Computer-Aided Design of Antimicrobial Peptides</title>
            <link>http://www.medworm.com/index.php?rid=3213488&amp;cid=s_37124_3_f&amp;fid=37124&amp;url=http%3A%2F%2Fwww.springerprotocols.com%2FAbstract%2Fdoi%2F10.1007%2F978-1-60761-594-1_6</link>
            <description>Antimicrobial peptides are ubiquitous in nature where they play important roles in host defense and microbial control. More than 1,000 naturally occurring peptides have been described so far and those considered for pharmaceutical development have all been further optimized by rational approaches. (Source: Springer protocols feed by Immunology)</description>
            <author>Springer protocols feed by Immunology</author>
            <type>news</type>
        <comments>http://www.medworm.com/rss/comments.php?id=3213488</comments>
            <pubDate>Fri, 22 Jan 2010 00:00:00 +0100</pubDate>
            <guid isPermaLink="false">3213488</guid>        </item>
        <item>
            <title>Production of Recombinant Antimicrobial Peptides in Bacteria</title>
            <link>http://www.medworm.com/index.php?rid=3213487&amp;cid=s_37124_3_f&amp;fid=37124&amp;url=http%3A%2F%2Fwww.springerprotocols.com%2FAbstract%2Fdoi%2F10.1007%2F978-1-60761-594-1_5</link>
            <description>We describe antimicrobial peptide production in E. coli based on forcing antimicrobial peptides into inclusion bodies, which is affective for the production of large quantities of antimicrobial peptides. Chemical reagents for cleaving peptide bond between antimicrobial peptides and fusion proteins such as cyanogen bromide and diluted acid are selective and provide antimicrobial peptides for biological studies in short time. (Source: Springer protocols feed by Immunology)</description>
            <author>Springer protocols feed by Immunology</author>
            <type>news</type>
        <comments>http://www.medworm.com/rss/comments.php?id=3213487</comments>
            <pubDate>Fri, 22 Jan 2010 00:00:00 +0100</pubDate>
            <guid isPermaLink="false">3213487</guid>        </item>
        <item>
            <title>Expression and Purification of Recombinant &amp;alpha;-Defensins and &amp;alpha;-Defensin Precursors in Escherichia coli</title>
            <link>http://www.medworm.com/index.php?rid=3213486&amp;cid=s_37124_3_f&amp;fid=37124&amp;url=http%3A%2F%2Fwww.springerprotocols.com%2FAbstract%2Fdoi%2F10.1007%2F978-1-60761-594-1_4</link>
            <description>Recombinant expression of &amp;alpha;-defensins can be obtained at efficient levels in Escherichia coli. Amplified &amp;alpha;-defensin or pro-&amp;alpha;-defensin coding cDNA sequences are cloned directionally between EcoRI and SalI sites of the pET-28a expression vector and expressed in E. coli BL21 RIS cells. Cells growing exponentially in nutrient-rich liquid medium are induced to express the recombinant protein by addition of 50&amp;nbsp;mM isopropyl &amp;beta;-d-1-thiogalactopyranoside for 3&amp;ndash;6&amp;nbsp;h. After bacterial cells collected by centrifugation are lysed in 6&amp;nbsp;M guanidine-HCl under non-reducing conditions, the expressed defensin fused to its 6xHis-34 amino acid N-terminal fusion partner is purified by affinity chromatography on nickel-NTA columns. A Met codon introduced at the N terminus...</description>
            <author>Springer protocols feed by Immunology</author>
            <type>news</type>
        <comments>http://www.medworm.com/rss/comments.php?id=3213486</comments>
            <pubDate>Fri, 22 Jan 2010 00:00:00 +0100</pubDate>
            <guid isPermaLink="false">3213486</guid>        </item>
        <item>
            <title>Strategies for the Isolation and Characterization of Antibacterial Lantibiotics</title>
            <link>http://www.medworm.com/index.php?rid=3213485&amp;cid=s_37124_3_f&amp;fid=37124&amp;url=http%3A%2F%2Fwww.springerprotocols.com%2FAbstract%2Fdoi%2F10.1007%2F978-1-60761-594-1_3</link>
            <description>We describe a bioassay-based method suitable for finding antibacterial lantibiotics from actinomycete strains and provide selected procedures for characterizing newly discovered lantibiotics for their antibacterial properties. (Source: Springer protocols feed by Immunology)</description>
            <author>Springer protocols feed by Immunology</author>
            <type>news</type>
        <comments>http://www.medworm.com/rss/comments.php?id=3213485</comments>
            <pubDate>Fri, 22 Jan 2010 00:00:00 +0100</pubDate>
            <guid isPermaLink="false">3213485</guid>        </item>
        <item>
            <title>Purification of Antimicrobial Peptides from Human Skin</title>
            <link>http://www.medworm.com/index.php?rid=3213484&amp;cid=s_37124_3_f&amp;fid=37124&amp;url=http%3A%2F%2Fwww.springerprotocols.com%2FAbstract%2Fdoi%2F10.1007%2F978-1-60761-594-1_2</link>
            <description>Human skin is a rich source of human antimicrobial peptides. Its cellular source is the keratinocyte, which terminally differentiates in the uppermost parts of the skin, eventually forming the stratum corneum, the horny layer. The easy availability of human stratum corneum makes it possible to identify and characterize human antimicrobial peptides with a biochemical approach. Moreover, the availability of lesional scales of patients with psoriasis, an inflammatory skin disease, allows the identification of human-inducible peptide antibiotics, which are absent in healthy skin. With this strategy, the beta-defensins hBD-2 and hBD-3, RNase-7 as well as psoriasin/S100A7 have been discovered as human antimicrobial peptides and proteins. (Source: Springer protocols feed by Immunology)</description>
            <author>Springer protocols feed by Immunology</author>
            <type>news</type>
        <comments>http://www.medworm.com/rss/comments.php?id=3213484</comments>
            <pubDate>Fri, 22 Jan 2010 00:00:00 +0100</pubDate>
            <guid isPermaLink="false">3213484</guid>        </item>
        <item>
            <title>Antimicrobial Peptides in Frog Skin Secretions</title>
            <link>http://www.medworm.com/index.php?rid=3213483&amp;cid=s_37124_3_f&amp;fid=37124&amp;url=http%3A%2F%2Fwww.springerprotocols.com%2FAbstract%2Fdoi%2F10.1007%2F978-1-60761-594-1_1</link>
            <description>Skin secretions from many species of anurans (frogs and toads) are a rich source of peptides with broad-spectrum antimicrobial activities that may be developed into agents with therapeutic potential, particularly for topical applications. This chapter describes the use of norepinephrine (injection or immersion) to stimulate peptide release from granular glands in the skin in procedures that do not appear to cause distress to the animals. The peptide components in the secretions are separated using reversed-phase HPLC on octadecylsilyl-silica (C18) columns after partial purification on Sep-Pak C18 cartridges. Peptides with antimicrobial activity are then identified by demonstration of their abilities to inhibit growth of Gram-negative (Escherichia coli) and Gram-positive (Staphylococcus aur...</description>
            <author>Springer protocols feed by Immunology</author>
            <type>news</type>
        <comments>http://www.medworm.com/rss/comments.php?id=3213483</comments>
            <pubDate>Fri, 22 Jan 2010 00:00:00 +0100</pubDate>
            <guid isPermaLink="false">3213483</guid>        </item>
        <item>
            <title>Isolation of NK Cells and NK-Like Cells from the Intestinal Lamina Propria</title>
            <link>http://www.medworm.com/index.php?rid=3127328&amp;cid=s_37124_3_f&amp;fid=37124&amp;url=http%3A%2F%2Fwww.springerprotocols.com%2FAbstract%2Fdoi%2F10.1007%2F978-1-60761-362-6_32</link>
            <description>Being exposed to food products, pathogens and harmless commensal bacteria, the mucosal immune system faces a constant challenge. Therefore, maintenance of a homeostatic balance is required to achieve tolerance to harmless bacteria and their products and to induce potent immunity to infection with pathogenic bacteria. Until recently, the literature on mucosal natural killer (NK) cells residing in the intestinal lamina propria was scarce and phenotype and function of gut mucosal NK cells did not receive much attention. Recently, data have become available identifying two distinct subsets of mucosal NKp46+ lymphocytes based on the expression of the orphan transcription factor ROR&amp;gamma;t. In many ways, the ROR&amp;gamma;t&amp;minus; subset resembled &amp;ldquo;classical&amp;rdquo; NK cells in that it was dev...</description>
            <author>Springer protocols feed by Immunology</author>
            <type>news</type>
        <comments>http://www.medworm.com/rss/comments.php?id=3127328</comments>
            <pubDate>Thu, 10 Dec 2009 00:00:00 +0100</pubDate>
            <guid isPermaLink="false">3127328</guid>        </item>
        <item>
            <title>Analysis of Uterine Natural Killer Cells in Mice</title>
            <link>http://www.medworm.com/index.php?rid=3127327&amp;cid=s_37124_3_f&amp;fid=37124&amp;url=http%3A%2F%2Fwww.springerprotocols.com%2FAbstract%2Fdoi%2F10.1007%2F978-1-60761-362-6_31</link>
            <description>The term uterine natural killer (uNK) cell is applied in mice to an abundant but transient NK cell population that undergoes unique, terminal differentiation within embryo implantation sites during endometrial decidualization and pregnancy. In mice, decidualization is induced by attachment and implantation of hatched, blastocyst-stage embryos. Within each implantation site, uNK cells proliferate and rapidly differentiate into highly restricted regions called decidua basalis and the mesometrial lymphoid aggregate of pregnancy (MLAp). uNK cells begin to die within healthy decidua basalis by day 8 of the 19&amp;ndash;20&amp;nbsp;day pregnancy of mice. By gestation day 12, uNK cell numbers have peaked and most uNK cells show in situ nuclear fragmentation indicative of disintegration. Morphological stu...</description>
            <author>Springer protocols feed by Immunology</author>
            <type>news</type>
        <comments>http://www.medworm.com/rss/comments.php?id=3127327</comments>
            <pubDate>Thu, 10 Dec 2009 00:00:00 +0100</pubDate>
            <guid isPermaLink="false">3127327</guid>        </item>
        <item>
            <title>Natural Killer Cells in Human Pregnancy</title>
            <link>http://www.medworm.com/index.php?rid=3127326&amp;cid=s_37124_3_f&amp;fid=37124&amp;url=http%3A%2F%2Fwww.springerprotocols.com%2FAbstract%2Fdoi%2F10.1007%2F978-1-60761-362-6_30</link>
            <description>Natural killer (NK) cells account for 70% of the leukocytes in the mucosal lining of the uterus (the decidua) in the first trimester of pregnancy. They are CD56superbright granulated cells expressing a repertoire of Killer-cell Immunoglobulin-like Receptors (KIR) skewed towards recognising HLA-C, which is the only classical class I MHC found on placental trophoblast cells. The function of decidual NK cells is not yet known, but there is evidence to suggest that they are involved in mediating trophoblast invasion into the decidua and modifying maternal spiral arteries to increase blood flow to the placenta. In order to characterise decidual NK cells and to understand their interactions with other cells at the maternal&amp;ndash;foetal interface, it is useful to be able to isolate these cells. H...</description>
            <author>Springer protocols feed by Immunology</author>
            <type>news</type>
        <comments>http://www.medworm.com/rss/comments.php?id=3127326</comments>
            <pubDate>Thu, 10 Dec 2009 00:00:00 +0100</pubDate>
            <guid isPermaLink="false">3127326</guid>        </item>
        <item>
            <title>In Vitro Development of Human Killer&amp;ndash;Immunoglobulin Receptor-Positive NK Cells</title>
            <link>http://www.medworm.com/index.php?rid=3127325&amp;cid=s_37124_3_f&amp;fid=37124&amp;url=http%3A%2F%2Fwww.springerprotocols.com%2FAbstract%2Fdoi%2F10.1007%2F978-1-60761-362-6_2</link>
            <description>The in vitro culture system outlined in this chapter allows for the delineation of events that occur during the development of CD34+ hematopoietic precursor cells into mature KIR+ human NK cells. This system can also be utilized to study the effects of gene overexpression or knockdown on the process of NK cell differentiation through retroviral transduction and long-term culture. The necessary soluble factors and contact-dependent conditions for in vitro human NK cell development have been worked out in our laboratory over the past 16&amp;thinsp;years. (Source: Springer protocols feed by Immunology)</description>
            <author>Springer protocols feed by Immunology</author>
            <type>news</type>
        <comments>http://www.medworm.com/rss/comments.php?id=3127325</comments>
            <pubDate>Thu, 10 Dec 2009 00:00:00 +0100</pubDate>
            <guid isPermaLink="false">3127325</guid>        </item>
        <item>
            <title>Activation of Human NK Cells by Malaria-Infected Red Blood Cells</title>
            <link>http://www.medworm.com/index.php?rid=3127324&amp;cid=s_37124_3_f&amp;fid=37124&amp;url=http%3A%2F%2Fwww.springerprotocols.com%2FAbstract%2Fdoi%2F10.1007%2F978-1-60761-362-6_29</link>
            <description>This chapter describes a protocol to assess activation of human NK cells following in vitro stimulation with malaria-infected red blood cells. Activation is assessed by flow cytometry, staining for cell surface expression of CD69 and accumulation of intracellular IFN-&amp;gamma;. Procedures are described for in vitro propagation and purification of Plasmodium falciparum parasites, separation of peripheral blood mononuclear cells from heparinised blood by density centrifugation, in vitro culture of PBMC and for staining and analysis of PBMC by flow cytometry. Some examples of typical FACS plots are shown. (Source: Springer protocols feed by Immunology)</description>
            <author>Springer protocols feed by Immunology</author>
            <type>news</type>
        <comments>http://www.medworm.com/rss/comments.php?id=3127324</comments>
            <pubDate>Thu, 10 Dec 2009 00:00:00 +0100</pubDate>
            <guid isPermaLink="false">3127324</guid>        </item>
        <item>
            <title>Studying NK Cell Responses to Ectromelia Virus Infections in Mice</title>
            <link>http://www.medworm.com/index.php?rid=3127323&amp;cid=s_37124_3_f&amp;fid=37124&amp;url=http%3A%2F%2Fwww.springerprotocols.com%2FAbstract%2Fdoi%2F10.1007%2F978-1-60761-362-6_28</link>
            <description>Here we describe methods for the in vivo study of antiviral NK cell responses using the mouse Orthopoxvirus ectromelia virus as a model, the agent of mousepox. The methods include those specific for the preparation and use of ectromelia virus such as the production of virus stocks in tissue culture and in live mice, the purification of virus stocks, the titration of virus stocks and virus loads in organs, and the infection of mice. The chapter also includes methods for the specific study of NK cell responses in infected mice such as the preparation of organs (lymph nodes, spleen, and liver) for analysis, the study of NK cell responses by flow cytometry, the adoptive transfer of NK cells, the measurement of NK cell cytolytic activity ex vivo and in vivo, and the determination of NK cell pro...</description>
            <author>Springer protocols feed by Immunology</author>
            <type>news</type>
        <comments>http://www.medworm.com/rss/comments.php?id=3127323</comments>
            <pubDate>Thu, 10 Dec 2009 00:00:00 +0100</pubDate>
            <guid isPermaLink="false">3127323</guid>        </item>
        <item>
            <title>Use of Inbred Mouse Strains to Map Recognition Receptors of MCMV Infected Cells in the NK Cell Gene Locus</title>
            <link>http://www.medworm.com/index.php?rid=3127322&amp;cid=s_37124_3_f&amp;fid=37124&amp;url=http%3A%2F%2Fwww.springerprotocols.com%2FAbstract%2Fdoi%2F10.1007%2F978-1-60761-362-6_27</link>
            <description>Genetically distinct inbred strains of mice that differ in their susceptibility to mouse cytomegalovirus (MCMV) are invaluable for dissecting complex host&amp;ndash;pathogen interactions. Their study has allowed the identification of host-resistance loci, including several activating NK cell receptors of major histocompatibility complex (MHC) class I. In this chapter, we provide a practical guide to the genetic mapping and functional characterization of NK cell receptors that control innate immunity against MCMV via specific recognition of infected cells. (Source: Springer protocols feed by Immunology)</description>
            <author>Springer protocols feed by Immunology</author>
            <type>news</type>
        <comments>http://www.medworm.com/rss/comments.php?id=3127322</comments>
            <pubDate>Thu, 10 Dec 2009 00:00:00 +0100</pubDate>
            <guid isPermaLink="false">3127322</guid>        </item>
        <item>
            <title>Identification and Analysis of Novel Transcripts and Promoters in the Human Killer Cell Immunoglobulin-like Receptor (KIR&amp;thinsp;) Genes</title>
            <link>http://www.medworm.com/index.php?rid=3127321&amp;cid=s_37124_3_f&amp;fid=37124&amp;url=http%3A%2F%2Fwww.springerprotocols.com%2FAbstract%2Fdoi%2F10.1007%2F978-1-60761-362-6_26</link>
            <description>We present here all of the techniques used to systematically determine if a gene possesses these types of control elements. (Source: Springer protocols feed by Immunology)</description>
            <author>Springer protocols feed by Immunology</author>
            <type>news</type>
        <comments>http://www.medworm.com/rss/comments.php?id=3127321</comments>
            <pubDate>Thu, 10 Dec 2009 00:00:00 +0100</pubDate>
            <guid isPermaLink="false">3127321</guid>        </item>
        <item>
            <title>KIR Genotyping by Multiplex PCR-SSP</title>
            <link>http://www.medworm.com/index.php?rid=3127320&amp;cid=s_37124_3_f&amp;fid=37124&amp;url=http%3A%2F%2Fwww.springerprotocols.com%2FAbstract%2Fdoi%2F10.1007%2F978-1-60761-362-6_25</link>
            <description>We describe here a simple and reliable multiplex PCR-SSP (sequence-specific priming) method for relatively rapid and inexpensive genotyping of 15 KIR genes using standard agarose gel electrophoresis. (Source: Springer protocols feed by Immunology)</description>
            <author>Springer protocols feed by Immunology</author>
            <type>news</type>
        <comments>http://www.medworm.com/rss/comments.php?id=3127320</comments>
            <pubDate>Thu, 10 Dec 2009 00:00:00 +0100</pubDate>
            <guid isPermaLink="false">3127320</guid>        </item>
        <item>
            <title>Analysis of the KIR Repertoire in Human NK Cells by Flow Cytometry</title>
            <link>http://www.medworm.com/index.php?rid=3127319&amp;cid=s_37124_3_f&amp;fid=37124&amp;url=http%3A%2F%2Fwww.springerprotocols.com%2FAbstract%2Fdoi%2F10.1007%2F978-1-60761-362-6_24</link>
            <description>We present an antibody panel allowing simultaneous assessment of the four major inhibitory KIRs and NKG2A. We further provide guidance on how to apply standard operating procedures to multi-color flow cytometry experiments. Finally, we discuss possibilities as well as limitations with the application of multi-color flow cytometry techniques to future studies of human NK cells. (Source: Springer protocols feed by Immunology)</description>
            <author>Springer protocols feed by Immunology</author>
            <type>news</type>
        <comments>http://www.medworm.com/rss/comments.php?id=3127319</comments>
            <pubDate>Thu, 10 Dec 2009 00:00:00 +0100</pubDate>
            <guid isPermaLink="false">3127319</guid>        </item>
        <item>
            <title>Functional Analysis of Human NK Cells by Flow Cytometry</title>
            <link>http://www.medworm.com/index.php?rid=3127318&amp;cid=s_37124_3_f&amp;fid=37124&amp;url=http%3A%2F%2Fwww.springerprotocols.com%2FAbstract%2Fdoi%2F10.1007%2F978-1-60761-362-6_23</link>
            <description>Natural killer (NK) cells are a subset of lymphocytes that contribute to innate immunity through cytokine secretion and target cell lysis. NK cell function is regulated by a multiplicity of activating and inhibitory receptors. The advance in instrumentation for multi-color flow cytometry and the generation of specific mAbs for different epitopes related to phenotypic and functional parameters have facilitated our understanding of NK cell responses. Here, we provide protocols for flow cytometric evaluation of degranulation and cytokine production by human NK cells from peripheral blood at the single-cell level. In addition to offering insight into the regulation of human NK cell responses, these techniques are applicable to the assessment of various clinical conditions, including the diagno...</description>
            <author>Springer protocols feed by Immunology</author>
            <type>news</type>
        <comments>http://www.medworm.com/rss/comments.php?id=3127318</comments>
            <pubDate>Thu, 10 Dec 2009 00:00:00 +0100</pubDate>
            <guid isPermaLink="false">3127318</guid>        </item>
        <item>
            <title>A Simple Method to Measure NK Cell Cytotoxicity In Vivo</title>
            <link>http://www.medworm.com/index.php?rid=3127317&amp;cid=s_37124_3_f&amp;fid=37124&amp;url=http%3A%2F%2Fwww.springerprotocols.com%2FAbstract%2Fdoi%2F10.1007%2F978-1-60761-362-6_22</link>
            <description>Natural killer (NK) cells were discovered in the 1970&amp;nbsp;s and named after their naturally occurring cytotoxic activity against tumor cells. It has recently become clear that NK cells are not just killers and that malignancy is unlikely to be the selective pressure driving the evolution of NK cells. Indeed, NK cells secrete a host of cytokines and chemokines that contribute to tissue remodeling at the feto-maternal interface and to both innate and adaptive immunity during infection. Moreover, in certain conditions, they cannot deliver functions cell autonomously, as they require priming from other cells, namely dendritic cells. Nevertheless, natural cytotoxicity is still considered an important parameter used to evaluate NK cell biology, both in the clinic and in the research lab. In thi...</description>
            <author>Springer protocols feed by Immunology</author>
            <type>news</type>
        <comments>http://www.medworm.com/rss/comments.php?id=3127317</comments>
            <pubDate>Thu, 10 Dec 2009 00:00:00 +0100</pubDate>
            <guid isPermaLink="false">3127317</guid>        </item>
        <item>
            <title>Probing the Interactions of NK Cell Receptors with Ligand Expressed in trans and cis</title>
            <link>http://www.medworm.com/index.php?rid=3127316&amp;cid=s_37124_3_f&amp;fid=37124&amp;url=http%3A%2F%2Fwww.springerprotocols.com%2FAbstract%2Fdoi%2F10.1007%2F978-1-60761-362-6_21</link>
            <description>Certain receptors on natural killer (NK) cells, which are specific for MHC class I (MHC-I) molecules, do not only interact with ligand expressed on opposing cell membranes (in trans) but also interact with those on the same cell membrane (in cis). Cis interactions have been demonstrated for only a small number of cell surface receptors. However, this has not been tested systematically, raising the possibility that additional receptors may be able to bind ligand expressed in cis. Here we describe a number of approaches to evaluate trans and cis binding of the Ly49A NK cell receptor to its H-2Dd ligand. These procedures should facilitate the investigation of cis/trans interactions of other receptor&amp;ndash;ligand pairs and simplify the analysis of NK cell receptor variants. (Source: Springer p...</description>
            <author>Springer protocols feed by Immunology</author>
            <type>news</type>
        <comments>http://www.medworm.com/rss/comments.php?id=3127316</comments>
            <pubDate>Thu, 10 Dec 2009 00:00:00 +0100</pubDate>
            <guid isPermaLink="false">3127316</guid>        </item>
        <item>
            <title>Determining Ligand Specificity of Ly49 Receptors</title>
            <link>http://www.medworm.com/index.php?rid=3127315&amp;cid=s_37124_3_f&amp;fid=37124&amp;url=http%3A%2F%2Fwww.springerprotocols.com%2FAbstract%2Fdoi%2F10.1007%2F978-1-60761-362-6_20</link>
            <description>Ly49 receptors in rodents, like KIR in humans, play an integral role in the regulation of NK cell activity. Some inhibitory Ly49 are known to interact with specific MHC I alleles to maintain tolerance to self tissues, and NK activation is triggered upon the loss of inhibitory signals due to pathological downregulation of self MHC I. Although a virally encoded ligand has been identified that can trigger NK cytotoxicity through an activating Ly49, some activating Ly49 also recognize MHC I and the role of most activating receptors in NK effector function remains poorly defined. As many Ly49 remain orphan receptors, we describe methods to unambiguously discern receptor&amp;ndash;ligand pairs. Additionally, we describe a method for the mutagenesis of Ly49 and MHC ligands that can be used to define ...</description>
            <author>Springer protocols feed by Immunology</author>
            <type>news</type>
        <comments>http://www.medworm.com/rss/comments.php?id=3127315</comments>
            <pubDate>Thu, 10 Dec 2009 00:00:00 +0100</pubDate>
            <guid isPermaLink="false">3127315</guid>        </item>
        <item>
            <title>Purification of Human NK Cell Developmental Intermediates from Lymph Nodes and Tonsils</title>
            <link>http://www.medworm.com/index.php?rid=3127314&amp;cid=s_37124_3_f&amp;fid=37124&amp;url=http%3A%2F%2Fwww.springerprotocols.com%2FAbstract%2Fdoi%2F10.1007%2F978-1-60761-362-6_1</link>
            <description>Accumulating data indicate that human natural killer (NK) cells undergo terminal maturation in secondary lymphoid tissues (SLTs) including lymph nodes (LNs) and tonsils. In addition, recent studies have revealed that maturing NK cells progress through at least five functionally discrete stages of development within SLTs. These discoveries provide unique possibilities for researchers to investigate the natural processes governing human NK cell development, as they exist in vivo, through analysis of NK cell maturational intermediates found in situ. Herein we describe a detailed, yet simple, four-step protocol for the viable enrichment and purification of human NK cell developmental intermediates from LNs and tonsils. (Source: Springer protocols feed by Immunology)</description>
            <author>Springer protocols feed by Immunology</author>
            <type>news</type>
        <comments>http://www.medworm.com/rss/comments.php?id=3127314</comments>
            <pubDate>Thu, 10 Dec 2009 00:00:00 +0100</pubDate>
            <guid isPermaLink="false">3127314</guid>        </item>
        <item>
            <title>Identification of NK Cell Receptor Ligands Using a Signaling Reporter System</title>
            <link>http://www.medworm.com/index.php?rid=3127313&amp;cid=s_37124_3_f&amp;fid=37124&amp;url=http%3A%2F%2Fwww.springerprotocols.com%2FAbstract%2Fdoi%2F10.1007%2F978-1-60761-362-6_19</link>
            <description>NK cell responses are regulated by a balance of inhibitory and activating signals, reflecting the net effect of interactions between receptors and ligands on target and effector cell surfaces. The identification of ligands for orphan NK cell receptors is key to enhancing our understanding of NK cell biology. Here we describe a strategy (protocol) for the identification of ligands for orphan NK cell receptors using signaling reporter cells in combination with a virus rescue system. (Source: Springer protocols feed by Immunology)</description>
            <author>Springer protocols feed by Immunology</author>
            <type>news</type>
        <comments>http://www.medworm.com/rss/comments.php?id=3127313</comments>
            <pubDate>Thu, 10 Dec 2009 00:00:00 +0100</pubDate>
            <guid isPermaLink="false">3127313</guid>        </item>
        <item>
            <title>Generating NK Cell Receptor-Fc Chimera Proteins from 293T Cells and Considerations of Appropriate Glycosylation</title>
            <link>http://www.medworm.com/index.php?rid=3127312&amp;cid=s_37124_3_f&amp;fid=37124&amp;url=http%3A%2F%2Fwww.springerprotocols.com%2FAbstract%2Fdoi%2F10.1007%2F978-1-60761-362-6_18</link>
            <description>We present here (i) a detailed protocol for the production and purification of soluble recombinant NK cell receptors tagged with human IgG1-Fc (thus termed receptor-Fc chimera or receptor-Ig fusion protein) and (ii) a protocol for cell staining with these recombinant receptor-Fc chimeras. As these recombinant proteins are produced in eukaryotic cells, we further discuss the glycosylation pattern of these receptors that might interfere with their ligand-binding phenotype. (Source: Springer protocols feed by Immunology)</description>
            <author>Springer protocols feed by Immunology</author>
            <type>news</type>
        <comments>http://www.medworm.com/rss/comments.php?id=3127312</comments>
            <pubDate>Thu, 10 Dec 2009 00:00:00 +0100</pubDate>
            <guid isPermaLink="false">3127312</guid>        </item>
        <item>
            <title>Methods to Identify and Characterize Different NK Cell Receptors and Their Ligands</title>
            <link>http://www.medworm.com/index.php?rid=3127311&amp;cid=s_37124_3_f&amp;fid=37124&amp;url=http%3A%2F%2Fwww.springerprotocols.com%2FAbstract%2Fdoi%2F10.1007%2F978-1-60761-362-6_17</link>
            <description>Different cellular immune responses are modulated by the cross talk between activating and inhibitory signaling pathways initiated via different cell surface receptors. Similarly, the killing of NK cells is controled by multiple activating and inhibitory surface receptors. In humans, the major NK triggering receptors, identified so far, include NKp80, 2B4 NKG2D, and CD16 and the natural cytotoxic receptors (collectively named NCRs) include NKp46, NKp44, and NKp30. The two major families of MHC-specific inhibitory receptors identified in humans are the Ig superfamily (KIR and LIR) and the C-type lectin (CD94/NKG2A) receptor superfamily. The different inhibitory receptors show diverse specificity and discriminate between different class I MHC proteins. Much is known about the function and ex...</description>
            <author>Springer protocols feed by Immunology</author>
            <type>news</type>
        <comments>http://www.medworm.com/rss/comments.php?id=3127311</comments>
            <pubDate>Thu, 10 Dec 2009 00:00:00 +0100</pubDate>
            <guid isPermaLink="false">3127311</guid>        </item>
        <item>
            <title>Introduction of shRNAs into Primary NK Cells with Lentivirus</title>
            <link>http://www.medworm.com/index.php?rid=3127310&amp;cid=s_37124_3_f&amp;fid=37124&amp;url=http%3A%2F%2Fwww.springerprotocols.com%2FAbstract%2Fdoi%2F10.1007%2F978-1-60761-362-6_16</link>
            <description>Natural killer (NK) cells are lymphocytes that provide an important line of defense against viruses and tumors. Technical hurdles in genetic modifications of primary NK cell ex vivo had limited our studies of protein function(s) in NK cell differentiation, acquisition of self-tolerance, and induction of anti-tumor responses. We used VSV-G-pseudotyped, EGFP-expressing lentiviral vectors to develop an efficient gene transfer system to modify gene expression in primary murine NK cells with or without prior IL-2 activation. Lentiviral vector transduction did not impair NK cellular viability, phenotype, or functions. We also demonstrated the use of this system in modifying differentiating NK cells derived from lentiviral-transduced murine hematopoietic progenitor cells. Furthermore, the same tr...</description>
            <author>Springer protocols feed by Immunology</author>
            <type>news</type>
        <comments>http://www.medworm.com/rss/comments.php?id=3127310</comments>
            <pubDate>Thu, 10 Dec 2009 00:00:00 +0100</pubDate>
            <guid isPermaLink="false">3127310</guid>        </item>
        <item>
            <title>Introduction of shRNAs into Human NK-Like Cell Lines with Retrovirus</title>
            <link>http://www.medworm.com/index.php?rid=3127309&amp;cid=s_37124_3_f&amp;fid=37124&amp;url=http%3A%2F%2Fwww.springerprotocols.com%2FAbstract%2Fdoi%2F10.1007%2F978-1-60761-362-6_15</link>
            <description>Natural killer (NK) cell lines are difficult to transfect using standard techniques, which limits the ability to establish long-term knockdown of proteins with short-hairpin (sh)RNAs. We have developed a method to stably knockdown protein expression in human NK-like lines by introducing shRNAs in retroviral vectors. After a single transduction with retrovirus, shRNA-containing cells can be selected with drug treatment or sorted for enhanced green fluorescent protein (EGFP) expression. With this method, protein expression can be stably decreased to less than 10% of wild-type levels. (Source: Springer protocols feed by Immunology)</description>
            <author>Springer protocols feed by Immunology</author>
            <type>news</type>
        <comments>http://www.medworm.com/rss/comments.php?id=3127309</comments>
            <pubDate>Thu, 10 Dec 2009 00:00:00 +0100</pubDate>
            <guid isPermaLink="false">3127309</guid>        </item>
        <item>
            <title>Lentiviral Gene Transduction in Human and Mouse NK Cell Lines</title>
            <link>http://www.medworm.com/index.php?rid=3127308&amp;cid=s_37124_3_f&amp;fid=37124&amp;url=http%3A%2F%2Fwww.springerprotocols.com%2FAbstract%2Fdoi%2F10.1007%2F978-1-60761-362-6_14</link>
            <description>Natural killer (NK) cells play a vital role in the control of cancer and microbial infections. A major hinderance in studying NK cells is the resistance of these cells to gene transfer. Considering over-expression and gene knockdown studies are crucial tools to study the biology of cells, technologies suitable for transfering genes into NK cells are invaluable. Among various technologies available for gene transfer, lentiviral-mediated transduction has been successful in introducing genes into NK cells. We have standardized methods of lentiviral infection in human and mouse NK cell lines. We obtain transduction efficiencies of 15% in the NK-92 cell line and 30&amp;ndash;40% in LNK, YT, and DERL7 cell lines. This method allows efficient and stable introduction of genes and shRNAs into NK cell l...</description>
            <author>Springer protocols feed by Immunology</author>
            <type>news</type>
        <comments>http://www.medworm.com/rss/comments.php?id=3127308</comments>
            <pubDate>Thu, 10 Dec 2009 00:00:00 +0100</pubDate>
            <guid isPermaLink="false">3127308</guid>        </item>
        <item>
            <title>Expression of cDNAs in Human Natural Killer Cell Lines by Retroviral Transduction</title>
            <link>http://www.medworm.com/index.php?rid=3127307&amp;cid=s_37124_3_f&amp;fid=37124&amp;url=http%3A%2F%2Fwww.springerprotocols.com%2FAbstract%2Fdoi%2F10.1007%2F978-1-60761-362-6_13</link>
            <description>Human NK-like cell lines are difficult to transfect using standard mammalian expression vectors and conventional transfection protocols, but they are susceptible to retroviral transduction as a means to introduce cDNAs. Our laboratory has exploited this technique to study a number of receptors in human NK cell lines. The method utilizes a bicistronic retroviral vector that co-expresses either drug resistance or enhanced green fluorescent protein (EGFP) in parallel with the gene of interest. After a single infection with recombinant retrovirus, transduced NK cells can be sorted for expression of EGFP or the transduced cell surface marker. Alternatively, cells expressing the transduced cDNAs can be selected for by treatment with neomycin, puromycin, or hygromycin. Using this method, the sort...</description>
            <author>Springer protocols feed by Immunology</author>
            <type>news</type>
        <comments>http://www.medworm.com/rss/comments.php?id=3127307</comments>
            <pubDate>Thu, 10 Dec 2009 00:00:00 +0100</pubDate>
            <guid isPermaLink="false">3127307</guid>        </item>
    </channel>
</rss>

